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ABSTRACT OF THE DISSERTATION
CORRELATING THE EFFECT OF DYNAMIC VARIABILITY IN THE SENSOR
ENVIRONMENT ON SENSOR DESIGN
by
Pulak Bhushan
Florida International University, 2021
Miami, Florida
Professor Shekhar Bhansali, Major Professor
This dissertation studies the effect of biofluid dynamics on the electrochemical
response of a wearable sensor for monitoring of chronic wounds. The research
investigates various dynamic in vivo environmental parameters (pH, temperature, and
evaporation) and correlates them with experimentally measured behavior with wound
monitoring as a use case. Wearable electrochemical biosensors suffer from several
unaddressed challenges, like stability and sensitivity, that need to be resolved for
obtaining accurate data. One of the major challenges in the use of these sensors is
continuous variation in biofluid composition. Wound healing is a highly dynamic
process with wound composition changing continuously, resulting in a dynamic
environment. This dissertation investigates the effects of several in vivo biochemical
and environmental parameters on the sensor response to establish actionable
correlations. Real-time assessment of wound healing was carried out through
longitudinal monitoring of uric acid and other wound fluid characteristics. A textile
sensor was designed using a simple fabrication approach combining conductive inks
with a polymeric substrate, for conformal contact with the wound bed. A <3%
degradation in the sensor response after prolonged mechanical stress, validated the
sensing capability under high mechanical deformation. The nanomaterial-based
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enzymatic sensor architecture for UA detection offered a sensitivity of 42.55 nA μM−1
cm−2, establishing the applicability of the sensor for accurate measurements in the
physiologically relevant range. The sensor was also found to be stable for a period of 3
days when subjected to physiological and elevated temperatures (37oC and 40oC)
confirming its relevance for long-term monitoring. Rigorous testing under dynamic in
vitro conditions showed a direct correlation between sensor response and the dynamic
parameters, with the results showing a ~20% deviation from the accurate UA reading.
The results confirmed that as a consequence of these parameters temporally changing
in the wound environment, the sensor response will be altered. The work thus
developed mathematical models correlating the effect of variability of these parameters
i.e., pH, temperature, sample volume, evaporation, and biofouling on sensor response
to allow for real-time sensor calibration. The clinical validation studies established the
feasibility of UA measurement by the developed electrochemical sensor and derive
correlations between the wound chronicity and UA levels. The protocols developed in
this work for the design, fabrication, and calibration of the sensor to correct for the
dynamic in vivo behavior can be extended to any wearable sensor for improved
accuracy.
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Introduction to Wearable Health Monitoring Systems

Continuous monitoring of a person’s health parameters can enable timely intervention
of healthcare providers and allow for the development of effective disease treatment
and management plans; thus, improving the overall therapeutic efficacy. The need for
continuous and active healthcare surveillance is fundamental especially in current times
of a pandemic.1,2 Conventional healthcare assessment techniques involve bulky and
expensive laboratory equipment, mandating skilled medical personnel for their
operation. Moreover, they require invasive procedures for sample collection (e.g.,
pricking for blood collection) with the general turnaround time being a couple of hours
or in some cases several days. The advent of point-of-care devices for bedside
assessment, eliminated the need for complex equipment, but still required complex
sample collection procedures while only offering single time measurements.3 This thus
necessitated the need for the development of sensing systems that could directly
interface to a person’s body or a specific organ to continuously measure the physical
and chemical signals generated.
1.1

Wearable Sensors

Wearable sensors have provided an elegant alternative to the conventional ways for
assessment of a person’s physiological status in a continuous and non-invasive manner.
They are body-borne systems that interact with the wearer and integrate a biological
element to measure health parameters to produce a signal that is then transmitted to an
associated electronic device. Over the last decade, the medical sensing paradigm has
been completely altered with the dawn of such wearable sensing technologies. The
significant advancements made in these devices have enabled clinicians to track vital
health parameters such as, body movement,4–7 heart rate,8–11 body temperature,12–15
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glucose16–19, and lactic acid17,20–23 levels, etc. in real-time to predict potential future
health risks and provide timely treatments. For instance, continuous monitoring of
electrograms such as an electrocardiogram (ECG)24,25 and electroencephalogram
(EEG)26,27 that measure electrical signals from the heart and brain respectively, can
allow for diagnosis of potential heart attacks or seizures or timely diagnosis of atrial
fibrillation. These devices are particularly beneficial for patients living in remote areas
where immediate medical assistance is not available, who require home assistance, or
are suffering from chronic diseases, to provide standard medical care remotely while
reducing the medical costs. The integration of these sensors into wearable accessories
that can be placed onto the body (e.g. watch or headband) or be incorporated within
garments can truly help realize personalized healthcare monitoring. The technological
advances made in the field of material science, semiconductor technology, sensing
mechanisms, miniaturized flexible electronics, and above all the growing awareness of
the need for personalized healthcare and treatment plans have led to significant research
in wearable technology. Furthermore, the convergence of industrial-scale fabrication
technologies, physiological sensing, and predictive data analytics has enabled the
translation of wearable devices from research laboratories to commercial medical
products.
A majority of the daily activities carried out by a person are inevitably dependent
on some physical activity. Continuous measurement of physical stimulus generated by
the body through wearable sensing systems provides an opportunity for predictive
analysis aiding in early diagnosis of a disease. Extensive research is being carried out
to develop systems that are mechanically robust and highly sensitive to accurately
detect the body signals while eliminating unwanted noise. While advances in material
science have led to the development of sensing platforms that are ultrathin, lightweight,
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mechanically resilient, self-healing, and can conformally attach to the human body;
implementation of nanostructured architectures28–32 have resulted in improved
sensitivity of the sensors. Some of the vigilant physical monitoring systems include
sensors that track heart rate, muscle movement, pressure, strain, and venous pulse
(Figure 1.1).

Figure 1.1. Examples of wearable sensing systems for tracking physical stimuli such as
heart rate, body temperature, strain, humidity, muscle monitoring, etc. for real-time
healthcare monitoring. Reproduced with permission.33 Copyright 2016, Wiley-VCH.
In addition, integrated platforms are being designed that implement an array of
several individual sensors to simultaneously measure multiple health parameters
providing a more holistic view of the person’s health.34–38 Although monitoring of
physical parameters is essential, biochemical profiling of biofluids can provide an even
more comprehensive overview of a person’s health. A majority of non-invasive
wearable biochemical sensors are still in the research stage and no commercial devices
that can provide real-time monitoring and therapeutics exist yet.

3

1.2

Wearable Chemical Sensors

Chemical sensing involves the detection of a particular analyte using a sensing element
and transforming the chemical information into an electrical signal using a transducer.
These sensors are particularly vital in the field of healthcare monitoring for the
detection of a multitude of diseases. For example, measurement of analytes such as
glucose39 and lactate40 in blood has been used for the detection of diabetes and kidneyrelated diseases, respectively. However, the conventional laboratory-based detection
techniques require collection of samples in a non-invasive manner (e.g., finger-pricking
for blood collection) posing a major healthcare hurdle. The need for sensors for
continuous temporal monitoring of analytes with a simple and non-intrusive sample
collection procedure is vital. Management of diseases like post-traumatic stress
disorder, may require continuous measurement of cortisol to prevent any sudden mental
breakdowns in the future.41 Similarly, complications associated with diabetes can lead
to the development of chronic ulcers, which with inefficient wound care management
may result in infections and traumatic amputations. However, existing wound care
practices are highly subjective, with no existing platforms for vigilant wound
monitoring. The development of continuous monitoring platforms for such diseases can
aid in clinical decision making thus improving the patient’s standard of life. Over the
last decade, several wearable chemical sensors have been developed for healthcare
diagnostics using optical,42–45 electrochemical16,17,21, and piezoelectric46,47 based
transduction mechanisms. Among these, electrochemical sensors have gained
particular attention owing to their simplicity, stability, sensitivity, and low cost. A
typical electrochemical sensor consists of two fundamental units: i) a receptor, and ii)
a transducer (Figure 1.2).
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Figure 1.2. Schematic illustrating the different functional components of an
electrochemical sensor, which includes a transducer, receptor, target analyte and the
sample biofluid. Reproduced with permission.48 Copyright 2014, Elsevier Inc.
The main role of the receptor is to specifically detect the target analyte in the
presence of potentially interfering chemical species, while the transducer is required to
convert the generated chemical signal to a readable electrical signal. Electrochemical
sensors are further classified based on the receptor type as, catalytic or affinity-based
sensors. Amongst these, enzymatic sensors, a class of catalytic-based sensors, have
received tremendous attention owing to their high specificity, sensitivity, and their
continuous measurement modality. Considerable efforts have been made recently in
this field resulting in the development of wearable electrochemical sensors that can
detect target analytes in biofluids such as sweat, interstitial fluid, tears, saliva, and
wound exudates. The following sections discuss the different electrochemical sensors
developed for different target biofluids in further detail.
1.2.1

Sweat-based sensors

Sweat is a complex biofluid containing a wealth of chemical information whose
profiling can be potentially utilized to obtain a deeper understanding of a person’s
health at the biomolecular level. While blood has conventionally been used as a sample
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for the detection of several diseases, researchers have established strong correlations
between the sweat and blood concentration of certain analytes such as glucose,39
thereby providing an opportunity to probe sweat for non-invasive long-term medical
monitoring. In order to identify the correlations between sweat and blood analyte
concentrations, recent research has been focused on understanding the underlying
fundamentals of sweat gland physiology.49,50 The research revealed that sweat
conductivity and volumetric sweat rate play a major role in determining the sweat
analyte concentrations. Researchers have utilized this rich biofluid to detect several
analytes panning from ions such as Na+,51–53 K+,17,54 Cl-, 55,56, and Ca+2 57 to metabolites
like glucose,17,58 lactate,17,22,54 ethanol,59–61 uric acid,38 etc. All the above-mentioned
analytes are directly linked to diseases such as diabetes, gout, alcoholism, and chronic
liver disease, and their continuous monitoring can allow for improved clinical
management of these diseases. Continuous monitoring of glucose using these wearable
sensors has been of particular interest since their need is necessitated for efficient
diabetes management. Some of the other state-of-the-art sweat based sensors developed
recently are shown in Figure 1.3. Different form factors have been explored based on
the target application, e.g. wristband or headband type sensors are preferable for
monitoring of athletes while patch-type sensors have been used to discretely adhere to
jointed areas or areas with a heterogeneous body topography (Figure 1.3). Multiplexed
detection platforms have also been explored for the diagnosis of diseases that require
the study of the interdependence of several health parameters.17,34,38 Moreover, systems
integrated with transdermal drug delivery modules62 have been developed to enable
active feedback therapy to prevent potential health issues. Such painless delivery
modules are highly desirable especially for patients requiring frequent shots, e.g. insulin
shots for diabetic patients.
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Figure 1.3. Recently developed wearable chemical sensors for continuous monitoring
of metabolites in sweat. a. Smart wristband for multiplexed detection of a panel of
analytes (glucose, lactate, Na+ and, K+) in sweat integrated to a flexible wireless
transmission system for easy analyte read-out17 b. Band-Aid style patch for continuous
detection of Na+ ions in sweat. The sensor patch was further integrated to an RFID
antenna for wireless data transmission63 c. A microfluidic wearable patch for sweat rate
measurement and colorimetric detection of analytes present in the sweat (glucose,
lactate, pH and chloride) 64 d. Tattoo-based screen-printed electrodes for ethanol
detection in sweat. The device consisted of an iontophoretic system to induce sweat and
integrated with flexible electronics for data recording and transmission61 and e. An
exploded view of the different layers in the commercial GlucoWatch (top). Photograph
representing semi-continuous glucose measurements using the GlucoWatch (bottom)65.
Reproduced with permission.66 Copyright 2018, Springer Nature.
1.2.2

Saliva-based sensors

Saliva is one of the biofluids that has been used for a long time for analyte detection
using laboratory-based techniques as well. The easy accessibility and richness in
biological constituents make saliva an excellent biofluid for non-invasive analysis.67
However, conventional techniques require processing of the collected saliva for further
analysis, which is eliminated by the wearable sensors to a certain extent. Considerable
progress has been made in the field of wearable saliva-based sensors, with primary form
factor being denture-based or mouthguard-based.68,69 Sensors have been designed for
monitoring a wide spectrum of analytes especially focused on analyzing oral
pathology70,71 and improving pharmacological efficiency. It is well known that the oral
cavity is a host to a multitude of bacteria. Analysis of the microbiome composition can
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provide valuable insights on the development of any bacterial infections within the
cavity due to a dental prosthetic or a secondary manifestation of a certain disease.72,73
As an examples, monitoring of fluoride activity has been carried out to serve as an
indicator of fluoride dentifrice efficacy using these sensors.74

Figure 1.4. Recent wearable chemical sensors for monitoring of metabolites in saliva.
a. Photograph of graphene-based sensors integrated onto a tooth for detection of
bacterial formation on tooth enamel. The changes in the electrical resistance were used
to quantify the growth of bacteria72 b. A mouthguard-based device for electrochemical
detection of salivary uric acid. The results show patients with hyperuricemia exhibiting
elevated uric acid levels in the saliva69 c. A mouthguard sensing platform for
measurement of salivary glucose using entrapment of glucose oxidase in poly(MPCco-EHMA). The results show a linear increase in the output current from the device
with increasing levels of glucose75. Reproduced with permission.76 Copyright 2018,
The Royal Society of Chemistry.
In addition, saliva contains analytes that permeate via para or transcellular paths
and can be used to evaluate systemic disorders. For example, a strong correlation has
been established for glucose concentrations in saliva and blood for patients suffering
from diabetes.77 Cortisol is another such analyte that has been used to estimate the stress
levels with direct correlation of saliva cortisol concentrations to circadian variations in
a person.78 Other analytes explored for detection using saliva as a biofluid are shown
in Figure 1.4. Besides the fact that saliva can be collected in a non-invasive and painless
manner, it is particularly compliant for clinical monitoring that requires frequent
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sampling. However, a major drawback of saliva-based sensors is the requirement for
pre-treatment steps, thus making it a lesser-explored biofluid compared to sweat.
1.2.3

Tear-based sensors

Tear is a biofluid that contains water, lipids, lysozymes, immunoglobulins, ions and,
analytes like glucose and urea.79 It is an easily accessible biofluid and has been
considered to be an intermediate fluid between the cerebrospinal fluid and the serum.79
Tear monitoring can be of particular importance for monitoring ocular and non-ocular
disorders.80 For instance, lipid monitoring in tears has allowed for the detection of
diseases like multiple sclerosis.79 On the other hand, researchers have primarily used
tear as a biofluid for measurement of glucose levels for diabetes management.81,82 An
ocular lens-based sensor was developed by a research group that electrochemically
measured glucose levels and transmitted the data wirelessly to the user (Figure 1.5).83
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Figure 1.5. A wearable tear-based smart contact lens for glucose monitoring. a.
Schematic illustration of the different components used in the developed soft, smart
contact lens b. Circuit diagram of the smart contact lens and c. Operation of the soft
and smart contact lens. The lens allows wireless transfer of power through the
integrated antenna. The LED turns on while the glucose measurements are recorded to
indicate the measurement in progress after which the results are wirelessly transferred
to the user. Reproduced with permission.83 Copyright 2018, American Association for
the Advancement of Science.
However, accurate correlations between the analyte concentrations present in
blood and tear have been rather questionable. Further, tear collection has been a major
challenge in the development of these sensors.84,85 Due to small volumes and fast
evaporation rates of the tear, collecting a sufficient amount of biofluid is challenging.
Recently, sensor-enabled lenses, also known as lab-on-the-eye devices, are being
developed by researchers to eliminate the hurdle of sample collection and tear
evaporation.86–89 Measurement of different metabolites such as lactate is also being
10

explored to serve as an indicator of hypoxic conditions.90 However, these sensors are
still in infancy and a considerable amount of clinical validation is required to extract
actionable information from these sensing platforms.
1.2.4

Wound exudate-based sensors

The biomolecular mechanisms explaining tissue regeneration and the reasons for poor
healing of a wound are still poorly understood. Wound exudates are thus being largely
explored to elucidate the underlying mechanisms of wound healing for improving the
therapeutic efficacy of drugs especially for chronic wounds. Biochemical processes that
govern tissue regeneration can be probed to better understand the healing process to
allow for improved wound care management. Until recently, while a lot of diagnostic
techniques were available for bedside assessment not many real-time wound assessing
techniques existed. Most of the traditional techniques relied on visual inspection,
subjective assessment, or optical measurements of the wound size and depth, with none
of the techniques offering continuous wound measurement modalities.91,92
Considerable progress has been made now for developing smart bandages that can
proactively monitor biomarkers in the wound milieu such as pH,93–96 temperature,97,98
uric acid, xanthine99–102, and bacterial metabolites to track wound healing in real-time.
Wound exudate pH has been studied predominantly owing to its direct correlation with
the different wound healing stages (Figure 1.6).103–105 Moreover, the differences in pH
variances among acute and chronic wounds allow for differential diagnosis of such
wounds.106 However, pH in a wound milieu is subject to change due to a multitude of
reasons. For instance, a bacterial infestation in the wound may tend to acidify the wound
environment. Furthermore, the pH may also change as a function of an underlying
disease, diet and medication of a person. Likewise, elevated wound bed temperature
has been known to suggest the manifestation of bacterial biofilms within the wound.
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Periwound temperature mapping has been identified as an easy way to determine the
wound areas requiring debridement to accelerate the healing process. However, body
temperatures vary from person to person making temperature not a very accurate
measure of wound healing. Smart bandages incorporating a multimodal sensing
approach are thus required to accurately assess the underlying cause of pH or
temperature changes.

Figure 1.6. Wearable smart bandages for wound bed pH monitoring. a. Schematic
illustration of the fabrication steps of a highly stretchable potentiometric sensor for pH
measurement b. Photograph of a bandage with integrated flexible pH sensors c. Realtime monitoring of pH and the sensor response under mechanical stress107 d.
Colorimetric pH sensor-based hydrogel loaded with a pH-sensitive dye for long-term
monitoring e. Images showing the changes in the color of the dressings when sprayed
with different pH solutions and f. Correlation plot depicting the data collected from the
images using a smartphone in comparison to a gold standard method108. Reproduced
with permission.109 Copyright 2018, Elsevier Inc.
Apart from multimodal approaches, integrated bandages are being designed that
combine a controlled drug release mechanism in conjunction with a sensing element to
determine when to deliver drugs to combat bacterial infections in wounds (Figure
1.7).110–112 However, these drug delivery modules are passive in nature, releasing a predetermined drug dosage. Systems with active spatial and temporal control over the drug
release based on the real-time wound status can allow for improved wound treatment.
Given the great variations in wound exudates depending on the patient’s medical
12

history, diet, and medication, ambiguity is an ever-present hazard that can be minimized
through self-referencing and longitudinal measurements. This provides an opportunity
for designing smarter bandages that can tap into an individual’s wound exudates to
determine proper treatments at a personalized level.

Figure 1.7. Recently developed wearable smart bandages enabled with integrated drug
release mechanisms. a. Photograph and micrograph of thermo-sensitive drug carriers
encapsulated in an alginate layer cast on a flexible heater b. Response of the thermosensitive drugs to varying temperatures113 c. Schematic showing the operational
principle of the engineered platform d. Release profile of cefazolin from the
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nanofibrous mesh at four different temperatures e. Effect of temperature on the release
rate of ceftriaxone encapsulated within the nanofibrous mesh upon cyclic heating110 f.
Illustration of a thread-based patch enabling active control over the release of different
drugs g. Effect of the number of activated fibers on cefazolin release from a textile
patch h. Image of the patch on the wound model and i. A typical fabricated bandage
used for releasing vascular endothelial growth factor into wounds in diabetic mice114.
Reproduced with permission.109 Copyright 2018, Elsevier Inc.
1.3

Challenges of Existing Wearable Systems

Despite all the recent progress made toward realizing wearable enzymatic
electrochemical sensors, these sensors still suffer from several unmet challenges that
require to be addressed for their successful commercial realization. Among the several
challenges that exist related to sensing, resilient materials, data acquisition, and
security, a major challenge has been the in vivo validation of these sensors.66 Owing to
the great variations in the biofluid composition from one person to another, there is
always an ambiguity in the environment that the sensor is placed in. Current wearable
electrochemical sensors do not take into account the dynamic environment that is
offered by these in vivo environments. The conventional electrochemical sensor
calibration establishes a mathematical relation between the steady-state environment
and the corresponding sensor response. However, in a complex in vivo environment,
the environment doesn’t necessarily assume a steady-state. With a change in the rate of
physiological processes the realized biofluid environment varies,115 subsequently
impacting the sensor output. Hence, the ability to model and actively correct for the
sensor response with respect to the variations in the environment is required to develop
a robust and accurate sensing system.
Enzymatic electrochemical sensing approaches offer significant advantages for
longitudinal measurements but suffer from stability issues owing to the loss of enzyme
activity due to temporal changes in pH and temperature.116 Enzymatic activity is
primarily dependent on pH and temperature, where the enzyme activity is highly
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compromised at high temperatures and deviation from the optimal pH leading to
conformational changes in the protein, altering its activity significantly. Alterations in
these parameters affect the enzyme activity leading to a sensor drift which further
results in erroneous sensor response. For example, the pH of a biofluid like sweat or
saliva is highly dependent on factors such as exercise or diet.117–119 A change in the
environmental pH changes the sensor functionality and needs to accounted for.
Likewise, the differences in the human physiological response to ambient temperature
can result in a different body temperature of a person, with the temperature also being
variable for the different body parts e.g. forearm, foot etc.120 Thus, the wearable systems
require an integrated sensing system to measure these parameters in conjunction with
the analyte sensor to provide accurate sensor readings. In a recent study, a glucosesensing patch/strip was developed with an integrated pH sensor for auto-calibration of
the glucose sensors.62 The researchers showed the difference in sensor response before
and after correction, demonstrating the importance of simultaneous measurement of
these parameters (Figure 1.8).
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Figure 1.8. Sweat-based glucose monitoring with real-time sensor correction. a. Optical
camera image of the subject on a cycle ergometer wearing the wearable patch b. Realtime humidity monitoring to check the sweat accumulation c. Multimodal glucose and
pH sensing to improve detection accuracy d. Measured sweat glucose concentrations,
pH levels, and corrected sweat glucose level based on the averaged pH (dotted line,
glucose concentration measured by a commercial glucose assay) e. Optical image of
the disposable strip-type sensors f. Optical images of the sweat uptake via the fluidic
channel of the strip g. Humidity monitoring using impedance measurements h. Sweat
glucose and pH monitoring using the disposable strip i. Comparison of sweat glucose
concentrations measured by the patch and a commercial glucose assay with and without
the pH-based correction j. Comparison of the sweat and blood glucose concentrations
before and after a meal k. Optical image of the transdermal drug delivery device on a
mouse l. Blood glucose levels of the mice for the treated groups (microneedles with the
drugs) and control groups (without the patch, microneedle without the drugs).
Reproduced with permission.62 Copyright 2017, American Association for the
Advancement of Science.

Over a transient measurement, evaporation of the biofluid is likely to happen
depending on the ambient environmental conditions.121 Sample evaporation has
emerged as a potential issue in wearable sensing systems, especially where the sample
volumes are low. In case of any biofluid like sweat or tear, the sweat or tear volume
and analyte concentration are transient and greatly depend on the environmental
conditions. Intuitively, as a result of this evaporation, the analyte concentration in the
biofluid will change and can be a significant source of error. The estimation of transient
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concentration in the fluid thus becomes highly dependent on the evaporation rate.122
The evaporation rate is not only governed by the ambient conditions (temperature and
humidity) but also by the substrate properties of the sensor123–125 (ability to retain the
sample). A level of complexity is further introduced by the interrelationship between
all the above-mentioned parameters. Correlation studies are thus imperative to
characterize the dependence of these individual parameters on each other and the sensor
response. Very few studies have been carried out to address the effect of evaporation
on analyte concentrations. One such preliminary study revealed that the sensor output
depends linearly on the evaporation rate assuming steady-state conditions.126 A similar
study modeled the interaction of the fluid with the substrate as a function of the
evaporation rate and environmental conditions.122 A classical convection-diffusion
equation was used to develop a correlation between the evaporation rate and salt
concentration. Based on the developed model, optimal flow rate conditions were
identified for accurate sensing at high time resolution. The evaporation rate not only
affects the analyte concentrations but also the sample transport mechanism. With ultralow sample volumes of the biofluid present (e.g. sweat, tear), transport of sufficient
amounts of sample is an issue with evaporation playing a major role. Theoretical
models are required to understand the correlation of sample transport on wearable
porous substrates while considering the evaporation effect. In a study, the authors report
that the rate of evaporation is strongly dependent on the overall geometry of the system.
They established a theoretical model to predict the evaporation rate from the substrate
and showed that the evaporation rate can be adjusted by modification of the substrate
geometry. While certain preliminary studies have been carried out to elucidate these
relations in point-of-care devices, novel sensors system architectures need to be
developed to address them for wearable sensors where these parameters change in real-
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time. Sweat rate is another parameter that varies, even within an individual, and is
dependent upon factors like hydration level, heat stress, and physical exercise.127,128 As
mentioned earlier in the chapter, it has been shown that the concentration of certain
analytes in the sweat is dependent on the sweat rate.129 Thus, measurement of sweat
rate along with the metabolite measurement is vital to accurately quantify the
metabolite levels. Furthermore, enzymes act as catalysts consuming target analytes and
are thus sensitive to analyte flux. Any changes in the flow rate of the biofluid will then
be accompanied by a change in the sensor output. This necessitates the development of
microfluidics integrated sensor systems to measure the sweat rate in tandem with the
chemical sensor to account for changes in the fluid flow rate.
Besides the above-described parameters, electrochemical sensing in complex
biological matrices is further challenged by sensor fouling resulting from adsorption of
extracellular proteins, cellular debris, accumulation of salt residues etc.130–132 The
adherence of these materials to the active area of the electrode impedes the diffusion of
the target analyte to the electrode surface, leading to a change in the sensor response. It
has been shown that macromolecules adsorb onto the electrode surface inhibiting the
electrocatalytic process resulting in a decreased sensor response. Several
electrochemical sensors utilize a polymeric gel layer over the active surface area to
improve the sensor stability.133–136 However, a study showed that prolonged exposure
of the sensor to human serum resulted in the fouling of the polymeric hydrogel, thus
decreasing the glucose diffusivity to the electrode.137 Therefore, proper selection of the
polymeric material and the properties of the designed gel is vital to minimize the
deleterious effects of biofouling on the sensor response.
The state-of-the-art wearable enzymatic sensors currently cannot quantify the
changes in these parameters in real-time in an in vivo setting. Simply, improvements on
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the sensing system designs by developing fundamental frameworks to understand the
effect of these parameters can contribute to providing reliable and actionable data to
aid clinical decision making. More robust and stable systems are required to ensure the
translation of these sensors to in vivo settings and enable their long-term use.
1.4

Wearable Wound Monitoring: A Use Case

Complications associated with wound care lead to the development of chronic wounds,
which with inefficient wound care management lead to increased risk of infections and
traumatic amputations.138 Chronic wounds are a major global healthcare challenge and
their real-time monitoring is vital to enable efficient wound care management. Present
wound care techniques are limited to analysis of subjective measures such as wound
width and depth.91,92 These approaches cannot be integrated onto a wearable construct
and do not offer continuous monitoring modalities. Thus, efforts have been directed
towards the development of electrochemical sensors for monitoring wound healing.
Smart bandages that employ enzymatic detection mechanisms for detection of purine
metabolites and other relevant biomarkers have been reported.99,102 However, none of
the bandages have been validated in an in vivo setting to the best of our knowledge.
A chronic wound milieu is a classic example of a dynamic environment owing
to its persistent inflamed state for long periods. These wounds are highly heterogenous
with the biomolecular signatures of the wound environment changing significantly with
time and the different healing stages. The pH of a wound is one such factor that varies
according to the wound status. It is well known that as a wound heals, the pH of the
wound milieu shifts from alkaline to acidic. Further, as a result of bacterial infestation
in a wound the pH of the exudate results in extremely low values.104 Similarly, temporal
changes in the wound temperature are observed as a consequence of several factors like
infection, inflammation, and change in the local blood flow rate.139 These dynamic
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changes in the pH and temperature can considerably compromise the enzyme activity
subsequently affecting the sensor response. During the inflammatory and proliferative
stages of wound healing, a majority of exudate is produced, with the production rate
being largely dependent on the characteristics of the wound. The local flux in the wound
environment can thus dynamically change as a function of the changing wound
conditions. The resulting erratic diffusivity pattern of the target analyte present in the
wound exudate due to the flux changes can again substantially affect the sensor
response.
A major challenge of low sample volume is further posed by the dry and low
exuding wounds. While sensing in low sample volumes is challenging due to
insufficient sensor wetting, such low volumes also tend to rapidly evaporate adding to
the sensing complexity. Additionally, the substrate properties of the wound dressings
play a major role in sample transport. The mass transport dynamics of the analyte to
the sensor surface are governed by the wicking properties of the dressing thus
governing the sensor response. To add to the complexity, electrochemical sensing in a
complex biofluid matrix, like wound exudate, is accompanied by sensor fouling
resulting from the formation of biofilms and adsorption of extracellular proteins (ECM)
over the sensor surface. The adsorption of these materials not only impedes the
diffusion of analyte but can also affect the enzymatic activity significantly. Therefore,
there is a need to design smart wound monitoring systems that track these dynamic
changes temporally allowing for on-chip calibration of sensing systems to enable the
development of wearable wound diagnostic systems. Future research should be focused
on understanding and modeling the intrinsic effects of the physiological wound
environment to improve sensor accuracy.
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1.5

Motivation and Layout of the Dissertation

The dynamic variability existing in biofluids in any wearable construct can result in a
confounded sensor response. As discussed earlier, potential factors such as sample
volume, evaporation rate, and sample flow rate of a sensor environment can affect the
electrochemical measurements and must be accounted for in the sensor design. Yet,
rarely does a consideration of the interplay of these dynamic factors motivate the design
of a sensor. Despite the extensive efforts dedicated to the development of wearable
sensors, a fundamental gap exists in understanding the effect of other existing in vivo
dynamic parameters in a sensor environment and their interdependence on each other.
Fundamental frameworks are required to establish these correlations and their effect on
the sensor response for development of robust sensor designs. Moreover, for real-time
measurement of parameters like sample volume and evaporation rate, incorporation of
conductivity or impedance-based measurements within the sensor design may offer an
advantage for quantitative measurements for sensor calibration.
This dissertation aims to study how the dynamic sensor environment affects the
sensor response and develop fundamental frameworks to understand the correlations
between them. The main focus is to develop analytical models to establish actionable
correlations for accurate quantification of target analytes in dynamic in vivo
environments. The central goal of the research is to develop mathematical frameworks
describing the dynamic sensor environment and sensor response, which correlate with
experimentally measured behavior with wound monitoring as a use case. The
correlations between the different competing parameters will be investigated to predict
how the sensor response scales as the environment changes.
Chapter 1 serves as an introduction to wearable sensing systems with a
particular focus on enzymatic electrochemical sensing systems. The chapter discusses
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the existing sensors that have been developed for quantification of analytes in several
biofluids like sweat, tears, wound exudates, and saliva. The existing issues in
translational of electrochemical sensors from traditional rigid substrates to flexible and
conformal substrates have been explored. Next, the challenge of a variable sensor
environment offered by the dynamic variability in biofluids parameters and their effect
on the sensor response has been discussed. Wound bed has been taken as a use case to
elucidate the different dynamic parameters offered by the biofluid (wound exudate) as
a function of wound healing. Subsequently, the capabilities and limitations of the
existing sensor systems have been discussed thereby explaining the motivation and
rationale of this dissertation. Chapter 2 elucidates the wound biochemistry and
presents an electrochemical approach towards long-term wound monitoring. The work
establishes a mediator-free enzymatic detection mechanism for uric acid, as a
biomarker for wound healing. A thorough physical and chemical characterization of the
proposed electrochemical sensor is presented in the chapter. The proposed mechanism
is characterized using a rigid sensor platform under ideal steady-state environments to
understand the fundamental reaction kinetics. Chapter 3 presents a novel method for
the fabrication of flexible textile-based electrochemical sensors for wearable
applications with wound monitoring as the use case. The fabrication strategy presented
allows sensor integration onto any kind of textile by taking advantage of an industrial
scale process, screen-printing. Further, the high mechanical durability and
electrochemical sensing performance of the fabricated sensors under tensile and
flexural stresses have been established in this chapter. Chapter 4 demonstrates the
application of the fabricated flexible sensors presented in Chapter 3 for electrochemical
detection of uric acid. An electrochemical sensing platform has been presented
consisting of an array of uric acid sensors for spatial mapping of uric acid in the wound.
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The physical and electrochemical characterization of the above flexible sensors and
their relevance for wound monitoring application has been detailed in the chapter. The
chapter further presents the design and characterization of a wearable system-on-chip
to be integrated with the flexible sensors for real-time on-body data collection and
wireless data transmission. Chapter 5 discusses the effect of various dynamic
environmental parameters on the sensor response. The effect of parameters like pH,
temperature, sample volume, and evaporation on sensor response has been discussed.
Correlation models between the dynamic parameters and the sensor response have been
presented

for

real-time

response

correction.

Chapter

6

investigates

the

biocompatibility of the developed sensor system and the sensor constituents. In-vitro
toxicity studies have been presented to elucidate the toxicity mechanisms if any, offered
by the sensor and the involved sensor materials. The cytotoxicity was assessed at both
an intercellular and intracellular level. Chapter 7 presents the human in vitro and in
vivo clinical validation studies carried out on chronic venous leg ulcer patients using
the developed wearable wound monitoring system discussed in the previous chapters.
The entire clinical trial protocol has been detailed for both in vitro and in vivo studies.
Correlations derived between the wound chronicity, wound size, and the measured uric
acid have been discussed. The sensor accuracy of the electrochemical sensor is further
established through validation using standard optical measurements. Confounding of
sensor response as a result of biofouling has been further presented in the chapter.
Preliminary studies presenting an approach towards real-time monitoring of bacterial
infection have also been discussed. The work also presents a new near-wound sensing
mechanism to allow for unobtrusive long-term wound monitoring. Chapter 8 provides
a synopsis of the work carried out in this dissertation and discusses the defining
problems that remain a challenge for the deployment of wearable sensors in real-time
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scenarios. The chapter also provides an outlook towards a future roadmap for creating
next generation integrated wearable devices.
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2
2.1

Uric Acid Detection on Rigid Sensors in a Steady-State Environment
Introduction

Chronic wounds pose an ever-increasing threat to a large fraction of the population and
significantly burden the healthcare economy with annual costs exceeding $25 billion in
the US.140 Wounds and burns represent more than 15% of all skin disease-related
deaths, with a reported prevalence of 4.64% in the U.S. population and an estimated
cost of $6 billion annually.141 As the population ages and sedentary lifestyle becomes
common, this burden is likely to grow, with wound care centers needing advanced tools
for rapid diagnostics and care. Hence, there is an urgent need to develop tools for wound
monitoring and healing prediction. Present wound monitoring techniques are largely
reliant on visual inspection of the wound and objective measures that can only be
performed by specific wound experts. While imaging techniques enable measurement
of wound width and depth,142,143 they are expensive and do not offer continuous
measurement modalities. In addition, amidst the repeated visits to the clinic, a delay in
medical attention may lead to further deterioration of the wound condition. Therefore,
the development of wound care technologies for continuous monitoring of wound
healing is imperative to facilitate timely therapeutic interventions for improved patient
care.
Efforts have been made recently to develop wound monitoring sensors that
enable continuous monitoring of various physical and chemical parameters of the
wound environment. Such parameters include pH and pressure,144–147 bacterial
metabolites148,149 and metabolites from the purine degradation pathway.150–153 The
estimation of these parameters would provide real-time insight into the wound status.
Placing or positioning these sensors directly over the wound bed may lead to sensor
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fouling and limit their lifetime, due to adsorption and occlusion of the active surface by
the wound debris. For example, the dead parenchymal cells and fibrinogen present in
the wound fluid can accumulate over the active surface area limiting the interaction
between the biomarker and the catalyst. This will result in lower sensitivity, degraded
detection limit, and a lifetime of the sensor. Furthermore, the materials utilized in the
sensor interface directly with the open wound and may pose biocompatibility issues
restricting the practical applicability of the sensor.
Uric acid (UA), a product of the purine metabolic cycle, is considered to be an
endogenous biomarker for wound healing assessment. As a consequence of cell rupture
at the wound site, adenosine triphosphate is released into the extracellular matrix. It
further breaks down into several metabolites, where the final reaction in the pathway is
the conversion of xanthine to UA.154 The UA levels at the wound site are known to
decrease as the wound heals, and hence serves as an accurate diagnostic indicator for
wound healing.155
In this chapter, a bi-enzymatic electrochemical sensor for monitoring UA levels
in human wound fluids is presented. This biosensor utilizes uricase (UOx) for UA
oxidation and horseradish peroxidase (HRP) for shuttling electrons between the
electrode surface and UOx. A nanocomposite of MWCNTs and AuNPs has been
investigated for improving the sensor response. In order to establish the feasibility of
the sensor to measure UA levels and understand the reaction kinetics of the sensor, the
sensor functionality in a steady-state environment using a rigid sensor has been
explored. The proposed electrochemical sensing approach utilizing uric acid as a
potential biomarker for continuous monitoring of wound healing may enable to advance
the existing wound care management technologies.
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2.2
2.2.1

Experimental
Materials

AuNPs (20 nm diameter) and MWCNTs (9.5 nm × 1.5 μm, CAS No. 308068-56-6)
were purchased from Sigma Aldrich, USA. Analytical grade horseradish peroxidase
(HRP, CAS No. 9003-99-0, 0.2 U ml-1) was purchased from ThermoFisher Scientific.
Lyophilized UOx powder (CAS Number 9002-12-4) containing 15∼30 U mg−1 was
purchased from Sigma Aldrich. UA, sodium hydroxide (CAS No. 1310-73-2), 30%
hydrogen peroxide (CAS No. 7722-84-1), sulfuric acid (95.0-98.0% H2SO4, CAS
No.7664-93-9), dimethylformamide (99.9% DMF, CAS No. 68-12-2), sodium
phosphate monobasic (NaH2PO4, CAS No. 10049-21-5) and sodium phosphate dibasic
(Na2HPO4, CAS No. 7558-7-4) were used of analytical grade. All aqueous solutions
were prepared in phosphate buffered saline (0.02 M, pH 7.8), prepared using NaH2PO4
and Na2HPO4 salts.
2.2.2

Methods and apparatus

Screen-printed carbon electrodes (SPCE) purchased from CH Instruments, Inc., United
States, were used to prepare the sensors. The working electrode was functionalized with
MWCNT solution prepared in DMF and dried at 60oC. Subsequently, AuNP solution
was drop-casted and dried at 60oC. Enzymes, HRP and UOx, were then immobilized
over the electrode by drop-casting, nitrogen drying, and subsequent washing in PBS.
All steps involving enzyme immobilization were carried out in an icebox to prevent
enzyme denaturation. Scanning electron microscopy (SEM JEOL 6330) and
transmission electron microscopy (TEM Philips CM200) was carried out to examine
the surface morphology of the nanocomposite electrodes. Electrochemical impedance
spectroscopy (EIS) was performed using an Autolab impedance analyzer to study the
nanocomposite-enzyme effect on the sensor property. All the readings were taken in a
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frequency range of 1 mHz to 100 kHz at a potential of 5 mV in a ferri/ferrocyanide
buffer. Various functionalized electrodes were studied to observe the influence of
nanomaterials and enzymes on the electron transfer resistance.
Cyclic voltammetry (CV) studies were performed using the analytical system
model CHI-230B potentiostat (CH Instruments, Inc.). A conventional three-electrode
cell assembly consisting of SPCE, Ag/AgCl as a reference electrode, and a Pt wire as a
counter electrode was used for the experiments. CV was performed to assess the
performance of the nanocomposite-enzyme functionalized electrode in varying
concentrations of UA. The measurements were performed at a scan rate of 0.02 V s-1
in a potential window of 0.2 V and -0.6 V. Control studies were carried out in the
absence and presence of different nanomaterials (Au and MWCNT) with the working
electrode being either bare, or nanomaterial and enzyme functionalized SPCE. A
Multiskan™ FC microplate reader (ThermoFisher Sc., USA) was used for absorbance
measurements.
Sensor stability was characterized under room temperature, physiological
conditions (37oC) and elevated temperature (40oC) over 7 days. The sensor response
was recorded every 8 h, and the electrode was left immersed in the UA solution in
between the sequential readings.
2.3
2.3.1

Results and discussion
Active surface area characterization of the biosensor

The surface morphology and the electron transfer resistance of the active surface were
characterized using SEM, TEM, and EIS respectively. A uniformly distributed structure
was observed for the MWCNTs modified electrodes, with MWCNTs having an average
diameter of 10 nm (Figure 2.1a). The darker area on the edges seen in the representative
TEM image shown in Figure 2.2a showed the multi-walled structure of the carbon
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nanotubes. This homogeneous topography as observed from the images offers
accelerated electron transfer.

Figure 2.1. SEM images of electrodes modified with a. MWCNTs b. MWCNT/Au and
c. MWCNT/Au/HRP/UOx. The MWCNT scaffold allowed for uniform distribution of
AuNPs on the electrode surface. The enzyme blanket over the nanocomposite structure
enabled efficient electron transfer between the enzymatic active site and the electrode.
d. Elemental mapping of AuNPs on MWCNT surface showing the even distribution of
nanoparticles over the MWCNT network.

Compared to the bare electrode, an increase in the Rct (semicircle area) for the
MWCNT electrode was observed from the Nyquist plot (Figure 2.3a). This decrease in
electron transfer resistance from 7.35 kΩ to 2.34 kΩ can be attributed to the conductive
properties offered by the MWCNT matrix. Subsequently, AuNPs were deposited over
the MWCNTs functionalized electrodes, resulting in a smoother and more uniform
surface as seen in Figure 2.1b. The AuNPs can be seen as bright spots and were spatially
distributed across the MWCNT framework. A low agglomeration level was observed
for the NPs, with a size distribution of 21.54 ± 1.7 nm.
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Figure 2.2. TEM images of electrodes modified with a. MWCNTs b. MWCNT/Au and
c. MWCNT/Au/HRP/UOx. The images show the synergistic interaction between the
walls of carbon nanotubes and AuNPs facilitating electron transfer over the electrode
surface. The immobilization of the enzyme on the electrode was confirmed when the
MWCNT matrix became indistinct as a result of enzyme deposition.
The elemental mapping of the composite surface further confirmed the uniform
distribution of MWCNTs and AuNPs over the electrode surface (Figure 2.1d). The
white pixels for MWCNT mapping represent their spatial distribution on the electrode
surface, while the distributed red pixels for the AuNPs show their assembly on the
MWCNT matrix. The TEM image revealed a physical interaction between the AuNPs
and the MWCNT walls which may enable accelerated electron transfer between the
two nanomaterials (Figure 2.2b). The resulting synergism due to the interactions
between the MWCNTs and AuNPs augmented their electron transfer properties; as
reflected by the decrease in Rct to 764.21 Ω after AuNPs deposition. The decrease in
the charge resistance suggested improved transfer kinetics offered by the
nanocomposite.156
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Figure 2.3. Nyquist plots of nanomaterial(s)-modified electrodes from 1 mHz to 100
kHz at a potential of 5 mV in ferri/ferrocyanide buffer. a. Plots of a bare electrode and
electrodes modified with MWCNT, MWCNT/Au and MWCNT/Au/HRP/UOx. A
decrease in the electron transfer resistance after MWCNT/Au immobilization showed
the improved electron transfer characteristics offered by the nanomaterials. b. Plots of
a MWCNT/Au/UOx electrode in presence and absence of HRP. An increase in the
charge transfer resistance confirmed the successful immobilization of the enzymes.
Randles equivalent circuit (inset) was used to fit the experimental data, where Rs is the
solution resistance, Rct is the charge transfer resistance, Cdl is the double layer
capacitance and Zw is the Warburg impedance.
Such a network of nanostructures allows for robust immobilization, improved
stability, and reduced leaching of the enzyme.157,158 It was observed that no
nanoparticles were visible after enzyme deposition, confirming the deposition of an
enzyme blanket over the nanocomposite matrix (Figure 2.1c). The high-resolution
TEM images showed the AuNPs, however, the MWCNT matrix was indistinct as a
result of the deposited enzyme layer (Figure 2.2c). This was further established by the
increase in the charge transfer resistance from 764.21 Ω to 1.06 kΩ, due to the enzyme
blanket over the nanomaterials. The EIS plot also shows an increased Rct after HRP
immobilization (from 1.06 kΩ to 1.66 kΩ) compared to the only UOx immobilized
electrode (Figure 2.3b). Immobilization of HRP over the UOx enzyme resulted in
inhibition of ions reaching the nanocomposite substrate, hence limiting the charge
transfer process.159
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2.3.2

Biosensor response to uric acid

UOx is a peroxisomal enzyme that belongs to the purine degradation pathway. It
catalyzes the oxidation of UA to 5-hydroxyisourate, which is followed by the
generation of hydrogen peroxide (H2O2) (Eq. 1). The formed 5-hydroxyisourate then
reacts with water to produce carbon dioxide and allantoin which is a soluble form of
urate (Eq. 2).
UA + O2 + H2 O → 5 − hydroxyisourate + H2 O2 (1)
5 − hydroxyisourate + 𝐻2 O → allantoin + 𝐶𝑂2 (2)
In this work, the UA levels were quantified by measuring the amount of H2O2 generated
by the UOx from a given sample. CV measurements were carried out at a scan rate of
0.02 V s−1 to monitor the production of H2O2 on the electrode. The H2O2 produced as a
result of UOx reduction binds to the heme (Fe(III)) group present in HRP. This leads
to the heterolytic cleavage of the oxygen-oxygen bond of H2O2.160 The process resulted
in the formation of a water (H2O) molecule and oxidation of the heme group to form an
intermediate product. The electron transfer from the electrode was further accelerated
by the presence of MWCNT/AuNPs nanocomposite (Figure 2.4). The use of AuNPs
supported on carbon fibers has been reported earlier to enhance the electrochemical
response of biofuel cells.161–163 Recently, bi-enzymatic sensors have been widely used
to develop biosensors owing to their improved performance characteristics.164,165 An
oxidase/peroxidase cascade leads to the reaction process occurring at a lower potential,
in turn improving the selectivity of the sensor.166
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Figure 2.4. Schematic representation of uric acid oxidation by UOx and hydrogen
peroxide reduction via HRP on a MWCNT/Au functionalized electrode. The illustrated
reaction was used in the sensor to quantify the UA levels in a given sample.
An Ipc of 7.8 µA was observed for the nanocomposite modified electrode in
presence of HRP compared to an Ipc of 3.86 µA without HRP, while the Epc of the
reaction was maintained at a potential of -0.4 V (Figure 2.5a). The double-fold increase
in the current response implied an accelerated electron transfer offered by the bienzyme system. The higher rate of increase in the cathodic current and a 0.2 V decrease
in the onset potential of the bi-enzyme system further confirmed the high electron
mobility offered by the electrode in the presence of HRP. The electrostatic interactions
in a coupled HRP-UOx system, lead to a decrease in the distance to be traversed by the
produced hydrogen peroxide to the active site of HRP, which in turn results in an
improved sensor response.
The electrodes modified with the individual nanomaterials, MWCNT, or
AuNPs, presented a 1.2 and 1.5 fold higher current intensities with respect to the bare
electrode (Figure 2.5a). The enhanced effect of AuNPs in comparison to the MWCNTs
can be attributed to the redox effect presented by gold. Owing to the redox reaction
happening on the surface of these nanoparticles, gold undergoes transitions in the
oxidation state facilitating the reduction of hydrogen peroxide.167 The presence of the
nanocomposite accelerates the electron transfer rate from the electrode, resulting in the
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increased current response. The nanocomposite modified electrode exhibited an Ipc of
7.8 µA, which was a ~2.5-fold improvement over the electrodes modified with the
individual nanomaterials. The inter-nanomaterial interaction between the MWCNTs
and AuNPs provides an efficient conducting interface for the electrons.168,169 While the
edged planes of the MWCNTs offer increased surface interactions owing to their high
surface-to-volume ratio, the AuNPs offer enhanced sensitivity through increased
conductivity. Moreover, the increased current response can be attributed to the
synergistic interaction of the enzyme with the nanocomposite. The UOx enzyme has an
isoelectric point of 7.5, and at a physiological pH of 7.8, the overall charge on the
enzyme is negative.170 This negative charge results in electrostatic interactions between
UOx and the positively-charged AuNPs (amine-functionalized), leading to greater
retention of the enzyme. Concomitantly, MWCNTs provide a nanoscale environment
for effective enzyme adsorption.171 The hydrophobic amino acid residues of the UOx
enzyme interact with the hydrophobic sidewalls of the MWCNTs allowing for facile
enzyme immobilization.172

Figure 2.5. a. CV response of 53 µM UA on a bare electrode, UOx electrode modified
with Au/HRP, MWCNT/HRP, MWCNT/Au, and MWCNT/Au/HRP. The higher slope
and lower overpotential of the MWCNT/Au modified bi-enzyme electrode showed the
improved reaction kinetics of the system. b. CV response of the nanocomposite bienzyme system as a function of UA concentration. Inset shows the linear plot of Ipc vs.

34

UA concentration, with a sensitivity of 2.5 nA µM-1. Each experiment was carried out
in triplicate (n = 3), and the data is represented as mean ± SD.
The nanocomposite bi-enzymatic sensor was evaluated with various
concentrations of UA through cyclic voltammetry. An increase in the cathodic peak
current was discerned as depicted in Figure 2.5b and was correlated with the UA
concentration. A linear current response was observed in the range of 50 µM to 650
µM, with a correlation coefficient (R2) of 0.87 (Figure 2.5b inset). The sensor
sensitivity was calculated from the slope of the calibration plot and found to be 2.5 nA
µM-1. The sensor responded to a lowest concentration of 9.91 µM suggesting its
applicability over the clinically relevant range of UA in wound fluids i.e. 236-823
µM.173 While the reported sensitivity of the sensor was marginally lower compared to
previously reported sensors (Table 2.1), the sensor is capable of detecting UA in the
physiological range. Moreover, none of the previous sensors report the sensor stability
at physiological conditions which is an important factor for wearable sensing purposes.
In any enzymatic sensor, elevated temperatures can result in an unstable sensor
response due to enzyme denaturation. This restricts the usage of these sensors under
physiological conditions over a long period of time.
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Figure 2.6. Change in the UA current response of a MWCNT/Au/HRP/UOx sensor
under room temperature, physiological conditions (37oC) and an elevated temperature
(40oC) over a period of 7 days. The electrodes showed a stable response for up to 2
days, after which the sensor response degraded. The sensors showed the highest
degradation rate when kept at an elevated temperature of 40oC. Each experiment was
carried out in triplicate (n = 3), and the data is represented as mean ± SD.

The long-term stability study of the developed sensor was carried out over a period of
7 days under physiologically relevant conditions at a UA concentration of 250 µM. The
time frame for the study was chosen since the dressings for chronic wound patients is
typically changed once per week. A 13% decrease in the current response was observed
for the sensor at room temperature, and the sensor also exhibited a stable response at a
physiological temperature of 37oC with just a 16% decrease in the current (Figure 2.6).
However, at an elevated temperature of 40oC, the sensor response was seen to degrade
by 18%. The stable response offered by the sensor under physiological conditions for a
long period demonstrates its feasibility for utilization in a wearable construct.
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Table 2.1. Comparison of uricase sensors for electrochemical detection of UA.
Sensor

Linear range

Sensitivity

Limit of detection

Graphene oxide-

20-490 μM

-

3.45 μM

Cu2ZnSnS4/UOx159

0.05-700 μM

0.0018 µA mM−1 cm-2

0.066 µM

Nafion/UOx-Zinc

10-456 μM

239.67 μA mM−1cm−2

5 nM

1000-10000 μM

4.0 μA mM−1 cm−2

22.97 µM

Au-rGO/UOx177

50-800 μM

2.89 μA mM−1 cm−2

7.32 μM

CNT/Au/HRP/UOx

50-650 µM

35.71 μA mM-1 cm−2

9.91 µM

UOx174

oxide nanorods175
Zinc oxide quantum
dots/UOx176

(This work)

2.4

Conclusion

A UA based enzymatic electrochemical sensor for continuous wound monitoring has
been reported in this chapter. The sensor comprises of a bi-enzymatic system coupled
with a nanocomposite of MWCNTs and AuNPs for signal enhancement. While the bienzymatic system facilitated an accelerated electron transfer rate, the presence of the
nanocomposite matrix allowed for higher enzyme loading. The sensor was capable of
sensitively detecting UA under the physiologically relevant range of UA levels found
in chronic wounds. The high stability of the sensor exhibited at physiological conditions
demonstrated its applicability for sensing in a wearable setting. Although the specificity
and selectivity of the sensors remain to be evaluated for practical applicability of the
sensor, the proposed approach is a step forward towards long-term wound monitoring.
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3
3.1

All-Printed Textile-Based Wearable Electrochemical Sensors

Introduction

Wearable sensors enabling on-body monitoring of health-related parameters have the
potential to revolutionize personalized healthcare technology. These sensors have
attracted significant attention owing to their ability to non-invasively monitor human
health and provide predictive analytics and treatment. Textiles represent an appealing
class of substrates for realizing such wearable sensors, especially where sensor
durability and wearability are essential requirements. Over the past few years, several
such sensors have been developed to monitor physical parameters such as body
temperature,178,179 electrocardiogram (ECG),180–182 body motion,183,184, and respiration
rate185,186. Unlike the notable effort that has been aimed at physiological monitoring,
research directed towards the development of textile-based electrochemical sensors has
been limited. Chemical sensors can provide real-time information about the
biochemical profile of an individual’s health yielding an in-depth insight into the
overall health status. They offer significant advantages for longitudinal measurements,
providing high sensitivity, specificity, and rapid response. Owing to the completely
printed embodiments of textile-based electrochemical sensors, these sensors can be
easily integrated into garments to provide vital health data for extended periods without
compromising user comfort.
The successful realization of textile-based electrochemical sensors requires the
translational of these systems from traditional rigid and planar substrates to flexible and
conformal substrates. Further, a fundamental requirement is that these sensors maintain
their sensing capabilities while accommodating high mechanical deformations, thus
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imposing additional fabrication constraints. While the rough topography offered by the
textile hinders the fabrication of planar surfaces, the strain-limiting materials lead to a
low mechanical durability of the sensors. Recently several fabrication techniques187–191
have been implemented, however not every textile is compatible with the fabrication
process or in compliance with the operational environment. Techniques like inkjet
printing and dyeing allow for sensor integration within the knitted structure providing
high mechanical durability but require complex processing and are expensive. Thick
film patterning techniques such as screen-printing187,192,193 and stamp transfer188 have
thus been commonly employed to fabricate sensors on a large scale at lower costs.
Screen-printing offers several advantages such as ease of printing and easy design
customization, however, concerns raise due to its incompatibility with non-planar and
highly porous substrates. Sensors printed on porous substrates tend to crack and
delaminate from the textile under mechanical deformation, leading to a sensor
failure.194 On the other hand, though the stamp transfer technique allows for printing
on rough substrates, it results in low sensitivity sensors due to nonplanar electrode
surfaces and exhibits low mechanical durability. The low sensor sensitivity can be
attributed to the discontinuous and rough surface offered by the printed sensor resulting
in poor electron transfer on the surface. Despite the considerable attempts made towards
realizing textile-based electrochemical sensors, fabrication routes to mechanically
robust and substrate compliant sensors are still lacking.
This chapter presents a facile approach towards fabrication of flexible textilebased electrochemical sensors for healthcare monitoring. The approach combines
screen-printing of flexible conductive inks with a low modulus polymeric substrate
(TPU), to yield a rugged platform for flexible electrochemical sensing. The utilization
of a thin stretchable polymeric substrate allows the sensor to intimately mate with the
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wearer’s body for conformal attachment. Sandwiching the inks between highly
stretchable TPU films led to the sensor exhibiting high mechanical resilience, and a
stable electrochemical response under high mechanical deformation. Furthermore, the
fabricated flexible electrochemical sensors can be ironed onto any textile substrate,
allowing for easy customization for any application. As a proof-of-concept, the printed
sensors were transferred onto a cotton gauze to be used as a breathable sensing substrate
for real-time wound monitoring. In addition, given a low softening point of the TPU
film (80oC), the transfer process is compatible with even heat-sensitive textiles.
3.2
3.2.1

Experimental
Materials

Flexible conductive Ag/AgCl (Creative Materials, 127-48E) and carbon inks
(DuPontTM IntexarTM PE671) were purchased for screen-printing the sensors.
Potassium ferricyanide (K3[Fe(CN)6], CAS No. 13746-66-2), potassium chloride (KCl,
CAS No. 7447-40-7), sodium phosphate monobasic (NaH2PO4, CAS No. 10049-21-5)
and sodium phosphate dibasic (Na2HPO4, CAS No. 7558-7-4) were obtained from
Sigma-Aldrich. All aqueous solutions were prepared in phosphate buffered saline (0.02
M, pH 7.8), prepared using NaH2PO4 and Na2HPO4 salts.
3.2.2

Flexible electrochemical sensor fabrication

The electrochemical sensors were fabricated by printing commercial flexible
conductive inks onto a stretchable thermoplastic polyurethane (TPU, TE-11C
DuPontTM) film, and subsequently heat laminating over a cotton gauze (thickness: 100
µm). Screen-printing technique was used for the fabrication of flexible sensors on
fabric, given its known advantages of low cost and large-scale production. The bilayer
TPU film consisted of a high recovery (50 µm) and a melt adhesive layer (25 µm),
backed by an adhesive barrier layer. Printing was performed using a hand-operated
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screen-printing setup. The sensor pattern was designed in SolidWorks 2013 software
and the design mask was cut out on an adhesive vinyl using a Silhouette cameo 3 die
cutter. The mask was then placed on a polyester screen (200-mesh size) and the ink was
transferred to the TPU substrate through a hand-held squeegee angled at 45°. A
sequential printing of the silver/silver chloride (Ag/AgCl) and carbon inks was carried
out following a curing step of 15 minutes at 80oC in a convection oven after each print
(Figure 3.1). The conductive inks were known to have excellent adhesion to the
elastomeric TPU substrate while exhibiting resistance to flexing and creasing.
Subsequently, an encapsulating TPU layer (TE-11C DuPontTM) was placed over the
printed sensors to define the working area (Ø:3 mm) and the contact pads resulting in
the flexible sensor construct. The entire assembly was later heat laminated over a cotton
gauze with a heat press at 130°C for 2 min, to obtain a textile-based sensor.

Figure 3.1. Schematic illustration of the flexible sensor fabrication process using the
screen-printing technique. Flexible inks (Ag//AgCl and carbon) were sequentially
screen-printed and cured onto the TPU substrate. To define the electrode area, the
printed electrodes were encapsulated with a TPU layer resulting in the complete flexible
sensor construct.
3.2.3

Mechanical Characterization

Linear stretching and bending characterization of the sensors was carried through a
custom-designed micro-tensile tester. The sensor was subjected to increasing levels of
strain up to 100% in 10% increments at a rate of 50 mm/min. The lateral bending study
was conducted by bending the sensor up to an angle of 180o in increments of 45o.
Optical and scanning electron microscopy (SEM JEOL 6330) was performed to analyze
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the changes at a microscopic level. The change in resistance as a function of stretching
and bending was logged to assess the changes in sensor conductivity.
3.2.4

Electrochemical Characterization

Cyclic voltammetry (CV) was performed using a CH Instruments (CHI-230B)
electrochemical analyzer. A 5 mM K3[Fe(CN)6] solution in 0.1 M KCl was used as the
electrolyte for the studies. CV plots were acquired in a potential range of 0.5 V to -0.5
V with a scan rate of 20 mV/s. All electrochemical characterization was performed by
either continuously applying a strain of 25% or a lateral bending of 90o and recording
CV every 15 minutes for a total of 60 minutes.
3.3

Results and Discussion

The fabricated electrochemical sensor was designed to have a three-electrode assembly,
wherein the Ag/AgCl ink serves as the pseudo-reference electrode (RE), while the
chemically inert carbon ink is used to realize the working (WE) and counter electrodes
(CE) (Figure 3.2a). A layer of TPU was heat laminated on the printed sensor to serve
as an encapsulation layer and define the working area and the contact pads. An optical
micrograph of the printed sensor along with the scanning electron micrograph
illustrating the planar surface morphology and cross-sectional structure of the sensor
are shown in Figure 3.2b, c, and d. Using mechanically flexible inks in combination
with an elastomeric substrate, led to the printed electrochemical sensors demonstrating
high resilience to stretching, torsional, and bending stresses (Figure 3.2e-g). Owing to
the low thickness of the TPU substrate, the sensor can also intimately couple with the
complex contours of the skin surface (Figure 3.2h).
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Figure 3.2. a. Schematic representing the exploded view of the entire sensor assembly
b. Optical micrograph of the top view of the sensor (Inset: magnified image of the three
electrodes) c. SEM image of the working electrode illustrating the smooth surface
morphology d. Cross-sectional profile of the sensor, showing the TPU substrate, ink
and the encapsulation layers. Images depicting the sensor under e. tensile f. flexural and
g. torsional stress and h. conformal attachment of the sensor to the epidermis.
A crucial step towards obtaining the proposed flexible sensor was the heat
lamination of the TPU encapsulation layer over the printed sensor. The heat lamination
process thermally anneals the sensor surface resulting in reduced ohmic resistance. The
higher temperature of the heat lamination process (130oC) compared to the ink curing
temperature (80°C) results in rearrangement of the conductive particles in the ink
resulting in a 50% decrease in the resistance for the working and counter electrodes (
Table 3.1). Another key challenge is the protection of sensors at high peak
strains that can occur upon large-scale deformation, thereby creating a potential for
sensor failure. The TPU encapsulation layer addresses this challenge by providing the
sensor with an additional degree of stretchability. Preliminary work aimed at
quantifying the flexibility of the printed sensor with and without the encapsulation
layer. The micrographs of the sensor surface under strain illustrate that the ink starts to
debond and develop cracks at a low strain level of 25% for a non-encapsulated sensor
(Figure 3.3a). On applying a tensile force to the underlying TPU substrate the printed
ink experiences shear stress. As a consequence of relatively low stretchability of the
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ink compared to TPU, the printed sensor starts to develop cracks and consequently peel
off the substrate. On removal of the external force, the ink is unable to recover its
electrical conductivity which would consequently affect the sensor response. In
contrast, an encapsulated sensor exhibited excellent mechanical resiliency even under
a strain of 100%. Sandwiching the printed ink between two highly stretchable TPU
layers resulted in the sensor undergoing a large ductile deformation before failing, in
contrast to the non-encapsulated sensor. As clearly evident from the micrographs shown
in Figure 3.3a, minimal cracks were seen to develop even at higher strains for the
encapsulated sensor. This can be attributed to the TPU encapsulation layer preventing
the propagation of transverse cracks across the ink layer. The blockage of crack
propagation thus allows the ink layer to reach its ductile yield point and stretch out
together with the TPU layers to large elongations causing no appreciable damage to the
sensor.195 The sensor thus exhibits a self-healing property causing only an 11% increase
in the resistance upon returning to an unstrained state.
a.

b.
0%

25%

200 µm

75%

200 µm

100%

200 µm

200 µm

c.

200 µm

200 µm

200 µm

200 µm

Figure 3.3. a. Optical micrographs of a printed non-encapsulated (top) and encapsulated
(bottom) sensor when subjected to different strain levels (0%, 25%, 75% and 100%).
Change in the ohmic resistance (△R/R) of the three electrodes (WE, CE and RE) as a
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function of b. strain and c. bending stress. A minimal change in △R/R validated the
sensor’s durability under mechanical stress. Each experiment was carried out in
triplicate (n = 3), and the data is represented as mean ± SD.

Table 3.1. Change in ohmic resistance (△R/R) of the three electrodes (WE, CE and
RE) after heat lamination of the TPU encapsulating layer onto the screen-printed
electrodes. The data is represented as mean ± SD.
Sensor

Resistance (Ω)

Electrode

Before encapsulation

After
encapsulation

1

2

3

4

5

RE

2.4 ± 0.2

1.83 ± 0.06

WE

24.37 ± 0.25

12.1 ± 0.1

CE

26.23 ± 0.12

13.63 ± 0.15

RE

2.17 ± 0.06

2.1 ± 0.1

WE

27.77 ± 0.15

12.47 ± 0.06

CE

34.43 ± 0.35

13.17 ± 0.12

RE

2.5 ± 0.00

2.07 ± 0.06

WE

24.6 ± 0.00

10.47 ± 0.12

CE

31.13 ± 0.06

13.43 ± 0.12

RE

2.02 ± 0.03

1.87 ± 0.06

WE

26.33 ± 0.06

16.47 ± 0.23

CE

30.2 ± 0.10

18.17 ± 0.12

RE

2.6 ± 0.00

1.93 ± 0.06

WE

28.73 ± 0.06

15.33 ± 0.06

CE

34.5 ± 0.17

19.67 ± 0.06

The electrochemical characteristics of the sensor were examined by performing cyclic
voltammetry using potassium ferricyanide as the electrolyte (Figure 3.4a). The
electroactive surface area of the printed sensor was estimated to be 0.05 cm2 using the

45

Randles-Sevčik equation (Equation 3.1) for a quasi- reversible electron transfer
process.
𝑛𝐹𝑣𝐷0 1/2

𝑖𝑝 = 0.446 𝑛𝐹𝐴 𝐶 0 (

𝑅𝑇

)

Equation 3.3.1

where ip is the peak cathodic current, n is the number of electrons transferred in the
redox process, F is Faraday’s constant, A is the electrochemical active area, D is the
diffusion coefficient, C is the bulk concentration of the analyte, R is the universal gas
constant, T is the temperature, and υ is the scan rate.
In a wearable environment, sensors are required to operate accurately under
continuous mechanical stress. Chronic wounds such venous leg ulcers or diabetic foot
ulcers are found in the gaiter area of the leg or on the foot, respectively. Previous studies
have shown an average radius of curvature found in these regions to be around 20o
196,197

. Thus, when the sensor is placed on a wound, the typical stretching and bending

stresses can be expected to be 0% and 20o, respectively. In the case of sensor
mishandling or a sensor being subjected to extreme conditions, a strain of 25% and a
bending of 90o may be expected. To ensure proper sensor functionality under these
conditions, the sensor was tested under continuous mechanical stress both under normal
and extreme conditions. Subsequently, the change in electrochemical response of the
sensor as a function of applied strain and bending moment was evaluated. The sensor
was subjected to a continuous strain of 25% with CV response recorded after every 15
minutes for a total of 60 minutes.
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a.

b.

c.

Figure 3.4. Electrochemical sensor response using a ferricyanide probe a. while the
sensor was under no mechanical stress. b. while the sensor was under a 0% and 25%
strain for a total of 60 min (inset: CV recorded every 15 min). c. while the sensor was
under 20o and 90o bending stress for a total of 60 min (inset: CV recorded every 15
min). Negligible changes in the Epc and Ipc were observed illustrating the sensor’s
ability to withstand prolonged mechanical deformations. I and Io represent the average
cathodic peak current obtained from the CV plot with and without mechanical strain
(stretching or bending) respectively. Each experiment was carried out in triplicate (n =
3), and the data is represented as mean ± SD.
A minimal deterioration in the sensor response was seen as indicated by the small
shifts (7.29%) in the cathodic peak current and the redox potentials (0.05%) under a
25% strain. Applying an external tensile stress on the printed sensor results in
development of cracks given the plastic nature of the components. At an increased level
of stress, the cracks start to widen resulting in a loss of electrical conductivity, which
in turn affects the ion transport properties on the active area. However, no noticeable
change in response after 15 minutes implies that cracks develop in the printed traces
within the first few minutes after which they remain latent (Figure 3.4b). The high
resilience of the sensors is indicative of the preservation of the surface microstructure,
a key characteristic of electrochemical sensing. A lateral bending study was performed
next, to study the sensor compliance toward bending stresses. The sensor was held bent
at an angle of 20o or 90o with CV being recorded every 15 minutes. As depicted in
Figure 3.4c, even under extreme conditions (90o), bending had no discernible effect on
the peak current (1.93%). As was seen earlier, bending stresses lead to a less than 5%
change in the electrical conductivity of the printed sensors even when bent at 180o.
Thus, a bending moment of 90o, causes no change in the microstructural properties of
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the sensor, thus resulting in a stable sensor response. The mechanical characterization
studies reveal that even though minor deformations may appear in the printed traces;
they have a negligible effect on the overall electrochemical behavior of the sensor.
While the sensors fabricated in this study are mechanically reliable for the wound
monitoring use case, previous studies have reported sensors with higher levels of
tolerance where negligible effect on the electrochemical response even after a 150%
strain for an extended period of time (150 min) was seen.198 Several other studies have
also explored the effect of ink composition on the conductivity and mechanical
robustness of the printed traces.199,200 In the future, different formulations of the printed
inks may be further explored to develop highly robust inks for fabricating wearable
sensors.
As mentioned earlier, these flexible sensors can be easily translated to any textile
substrate to well-suit any apparel-based application. To align with the use case of this
study i.e., wound monitoring, the printed sensors were transferred onto a cotton gauze
as the substrate (Figure 3.2b). Such sensors can be used for real-time monitoring of
wound severity and help determine proper treatment and therapeutic efficacy.
3.4

Conclusion

In summary, a flexible electrochemical sensor exhibiting high mechanical resilience
has been demonstrated. The sensor is realized by screen-printing conductive inks on a
polymeric elastomeric substrate, TPU. By integrating a stretchable encapsulation layer,
the printed sensor can withstand high mechanical stresses. Tensile and flexural
characterization of the sensors revealed that a linear stretching of up to 100% and
bending up to 180o have a negligible effect on the mechanical properties of the sensor.
Furthermore, the thermal annealing of the printed sensors during the encapsulation
process resulted in a uniform surface terrain and a ~50% reduction in the ohmic
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resistance. The electrochemical characteristics of the sensor were also shown to be
highly resilient (<5% deviation) to any mechanical deformations. This work also
presents a facile and inexpensive process for the integration of flexible electrochemical
sensors on textiles to ensure user comfort and wearability. Further improvements can
be targeted towards tailoring the pristine inks and the substrates to impart additional
levels of stretchability to the sensors. Coupling electrochemical sensing modalities with
flexible and stretchable platforms can offer unprecedented opportunities for the
development of next-generation electrochemical sensors. Novel processes for
synthesizing stretchable inks and large-scale fabrication of electrochemical sensors
hold great promise to transform personalized healthcare monitoring.
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4
4.1

Uric Acid Detection on Flexible Sensors in a Steady-State Environment
Introduction

Flexible biosensors have been extensively explored for a plethora of applications, in
particular for healthcare monitoring owing to its advantage of continuous
montioring.17,201,202 Apart from the sensors that track physiological parameters203,204 of
the body, electrochemical sensors have been explored for monitoring of the chemical
information present in biofluids like sweat,17,205 interstitial fluid,206 wound
exudates100,102, etc. Chemical sensors have the potential to capture real-time changes in
the biomarker levels in a rapid, continuous and a non-invasive manner. Coupled with
physical sensors, these sensors can provide a comprehensive overview of a person’s
health. For example, uric acid concentration in wound exudates can be explored as a
biomarker for real-time monitoring of the progress of wound healing coupled with a
pressure sensor to monitor chronic pressure ulcers. Unlike conventional rigid
electrochemical systems, flexible sensors offer extended scope for high degree of
functional integration while conformally interfacing with the human body.
Translational of the traditional sensing mechanisms to wearable substrates has
eliminated the need for sophisticated equipment and skilled personnel providing realtime actionable data directly to the healthcare provider.
Potential flexible substrate materials that have been considered for development
of such sensors include, polyimide (Kapton),62,207 polyethylene terephthalate,208,209
paper210–212, and textiles.189,213 Plastic-based substrates such as polyimide, offer a planar
surface for efficient electrochemical sensing and allow for easy bending, however, they
do not entail stretching capabilities restricting their use in many applications. Further,
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owing to the plastic component of these substrates they have a compromised user
compliancy. For instance, a plastic substrate like polyimide may result in patient
discomfort when placed directly on an open wound; that may subsequently result in an
inflammatory response. Thus, textile-based substrates for these sensors213,214 have been
extensively explored to overcome the comfortability issues. In addition to their
excellent mechanical resiliency, these sensors can be seamlessly integrated to any
apparel for user comfort especially accommodating long-term monitoring applications.
However, due to the non-planar surface characteristics (dependent on the type of
textile) of these sensors they generally demonstrate low sensor sensitivities owing to
the poor electron transfer. Despite the major advances made towards development of
flexible electrochemical sensors significant amount of effort is required to couple
mechanically compliant substrates with efficient electrochemical sensing capabilities
to develop sensitive next-generation devices.
In this chapter, a textile-based flexible electrochemical sensor has been reported
for detection of uric acid (UA) for real-time wound monitoring. The flexible sensors
fabricated in the earlier chapter have been assessed for their electrochemical properties
for detection of UA. While the elastic nature of thermoplastic polyurethane (TPU)
allowed the sensors to undergo high mechanical stress, its biocompatibility made it a
suitable candidate for wound monitoring. The detection platform implements an
enzymatic electrochemical sensing modality to measure UA for longitudinal wound
monitoring. The tested sensing system consisted of an array of four UA sensors
integrated onto a single wound dressing to spatially map the UA levels across the
wound area. The electron transfer mechanism and the sensor’s applicability to sense
UA in real biofluids has been explored in detail. The flexible sensors have been further
interfaced with a low-cost custom designed wearable electronic system to enable real-
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time collection and wireless transmission of the sensor data to achieve a fully integrated
wearable system.
4.2
4.2.1

Experimental
Materials

AuNPs (20 nm diameter) and MWCNTs (9.5 nm × 1.5 μm, CAS No. 308068-56-6)
were purchased from Sigma Aldrich, USA. Analytical grade horseradish peroxidase
(HRP, CAS No. 9003-99-0, 0.2 U ml-1) was purchased from ThermoFisher Scientific.
Lyophilized UOx powder (CAS Number 9002-12-4) containing 15∼30 U mg−1 was
purchased from Sigma Aldrich. UA (CAS No.: 69-93-2), sodium hydroxide (CAS No.
1310-73-2), 30% hydrogen peroxide (CAS No. 7722-84-1), sulfuric acid (95.0-98.0%
H2SO4, CAS No.7664-93-9), dimethylformamide (99.9% DMF, CAS No. 68-12-2),
potassium chloride (KCl, CAS No. 7447-40-7), sodium phosphate monobasic
(NaH2PO4, CAS No. 10049-21-5) and sodium phosphate dibasic (Na2HPO4, CAS No.
7558-7-4) were used of analytical grade. All aqueous solutions were prepared in
phosphate buffered saline (0.02 M, pH 7.8), prepared using NaH2PO4 and Na2HPO4
salts.
4.2.2

Sensor functionalization

Fabricated screen-printed flexible electrodes were used for UA detection. The working
electrode of the fabricated sensor was first functionalized with a MWCNT dispersion
prepared in DMF and dried at 60oC to evaporate the solvent. This was followed by
casting of AuNP solution (OD: 50) and drying at 60oC for 5 minutes. The enzymes
HRP and UOx, were then immobilized over the electrode via physisorption, nitrogen
drying and thorough washing with PBS. All steps involving enzyme immobilization
were carried out in an icebox to prevent enzyme denaturation. For control studies, a
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monoenzymatic (UOx) electrode was functionalized containing either of the
nanomaterials (MWCNTs or AuNPs).
4.2.3

Sensor characterization
The surface morphology and nanoparticle distribution of the functionalized

working electrode was studied through scanning electron microscopy (SEM JEOL
6330) and transmission electron microscopy (TEM Philips CM200). Electrochemical
impedance spectroscopy (EIS) was performed using an Autolab impedance analyzer to
study the effect of nanoparticles on the charge transfer properties of the functionalized
sensors. The readings were taken in a frequency range of 1 mHz to 100 kHz at a
potential of 5 mV using a 5 mM ferricyanide ferrocyanide buffer as the probe.
Electrochemical active surface area characterization of the electrodes was carried out
via cyclic voltammetry (CV). CV was performed using a CH Instruments (CHI-230B)
electrochemical analyzer, with a 5 mM K3[Fe(CN)6] solution in 0.1 M KCl used as the
electrolyte. The control measurements were acquired in a potential range of 0.5 V to 0.5 V with a scan rate of 0.02 V s-1. In order to estimate the reaction kinetics of the
functionalized electrode, measurements at eight different scan rates (10, 20, 50, 100,
200, 300, 400, and 500 mV s-1) were carried out.
Chronoamperometric studies were performed using an analytical system model
CHI-230B potentiostat (CH Instruments, Inc.). Chronoamperometry was performed to
assess the response of the functionalized electrode to varying concentrations of UA.
Following sensor conditioning, each measurement was performed for 60 s at an applied
potential of -0.6 V. Control studies were carried out to assess the sensor response with
respect to each functionalized layer. Sensor stability was characterized at room
temperature (25oC), physiological conditions (37oC) and at an elevated temperature
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(40oC) over a period of 7 days. Sensor response was recorded every 12 h, and the
electrode was left immersed in the buffer solution in between the sequential readings.
4.2.4

Wearable electronic system design

A miniaturized electronic circuit system was designed for electrochemical and
temperature measurements. The potentiostat system was capable of performing
chronoamperometry measurements from each of the four sensors individually. Each 3electrode potentiostat channel contains an analog front-end (AFE, LMP9100 from
Texas Instruments (TI)) with software-adjustable bias and gain. The system also
contains a 100 kΩ negative temperature coefficient (NTC) thermistor in a voltage
divider circuit with a 49.9 kΩ resistor. The system is controlled by a Bluetooth Low
Energy (BLE) system-on-chip (SoC, BLE113 from TI) which reads the output of each
AFE through a quad analog-to-digital converter (ADC, ADS1115 from TI), and
digitizes the analog output of the potentiostat. Another analog input pin on the SoC is
used to read the output of the thermistor to determine the wound bed temperature. After
reading the electrochemical and temperature data, the SoC was programmed to operate
in either stream mode or save mode. In stream mode, the device samples the channels
at 5 Hz and transmits data over BLE to a data aggregator. In save mode, the device
wakes up once per hour and samples at 1.3 Hz for 1 minute per channel, then saves the
data to an on-board 2 Mb flash memory chip (M24M02, StMicrolectronics) and goes
back to sleep. For long-term use, the system was powered by a 350 mAh 3.7 V lithium
polymer battery and was encapsulated in flexible silicone to protect the electronics from
environmental moisture and ensure user comfort. A custom Python user interface was
also designed for device configuration and data aggregation. After connecting to the
device, the user can initialize the measurement, configure the gain and bias of the
potentiostat, and view a graphical display of the potentiostat currents, temperature
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value, and battery level. The user can then either stay in stream mode or switch to
memory mode for long-term studies. The same interface is used to retrieve, view, and
save the data in memory after the study is complete.
A custom rigid-flex interconnect was further designed to interface the backend
electronic system and the flexible UA sensors. A 12-pin Flat Flex Connector (FFC)
ribbon cable was attached to the two 12-pin FFC headers connected on the electronic
system and a breakout PCB board. The breakout board is then attached to the contact
pads on the fabricated sensors with a room-curable conductive silver epoxy to complete
the connection.
4.3
4.3.1

Results and Discussion
Sensor surface characterization

Owing to the fast electron mobility offered by MWCNTs and AuNPs, they were used
as catalysts in the UA detection mechanism. The nanomaterials provide a high surface
area for enzyme immobilization allowing for higher loading, improved stability and
reduced leaching of the enzyme. The surface morphology (Figure 4.1a) and electron
transfer characteristics of the electrode were analyzed through SEM, EIS and cyclic
voltammetry, respectively. The scanning electron micrograph of the MWCNT
functionalized electrode illustrated the mesh-like distribution of the MWCNTs over the
electrode surface (Figure 4.1b), with an average nanotube diameter of 10.05 ± 1.5 nm.
The images revealed that the uppermost layer consisted of a low-density network of
randomly oriented nanotubes. The porous structure (higher surface area) offered by the
MWCNTs facilitates higher enzymatic loading resulting in improved current density.
The different shades of black in the TEM images represented the multi-walled structure
of the nanotubes (Figure 4.1d),. The unique electron transfer properties offered by the
nanotubes as a result of this planar structure was further confirmed by the reduction in
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charge transfer resistance from 2.4 kΩ to 698 Ω after their deposition (Figure 4.2).
Furthermore, an increase in the double layer capacitance after MWCNT deposition
revealed their capacitive nature.

Figure 4.1. Representative SEM and TEM images of functionalized flexible electrodes
illustrating the uniform nanoparticle distribution over the electrode surface. SEM
images of a. Bare b. MWCNT c. MWCNT-AuNPs functionalized electrodes. Scale bar:
200 nm, TEM images of d. MWCNT e. MWCNT-AuNPs. The synergistic interaction
between the nanomaterials resulted in improved electron transfer between the active
site of the enzyme and the electrode.
The immobilization of AuNPs over the MWCNT network, resulted in a
homogenous topography of the electrode surface (Figure 4.1c). Spheroidal shaped
nanoparticles were seen decorated over the MWCNT network, with a mean particle
size of 20.75 ± 1.2 nm implying a spatial distribution of the gold nanoparticles with a
low agglomeration level. The synergistic interaction between the two nanomaterials,
improved their electron transfer properties; as was reflected by the decrease in Rct to
270 Ω (Figure 4.2). The TEM image illustrated the Van Der Wall interactions between
the AuNPs and the MWCNTs, where the AuNPs were seen to strongly cohere to the
walls of the nanotubes (Figure 4.1e). The decrease in the charge resistance suggested
an improved transfer kinetic characteristic offered by the MWCNT-AuNPs
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nanocomposite.156 The successful immobilization of the enzyme was signified by the
increase in the Rct of the electrode to 582 Ω as shown in Figure 4.2. Immobilization of
the enzymes over the nanocomposite functionalized electrode resulted in inhibition of
ions reaching the nanocomposite substrate, hence limiting the charge transfer
process.215

Figure 4.2. Nyquist plot of bare, MWCNT, MWCNT-AuNPs and MWCNT-Au-HRPUOx functionalized flexible electrodes showing the improved electron transfer rate as
a result of nanoparticle immobilization. A ferri/ferrocyanide probe was used to take
impedance readings in the frequency range of 1 mHz to 100 kHz at a potential of 5 mV.
Randles equivalent circuit (inset) was utilized to fit the experimental data, where Rs is
the solution resistance, Rct is the charge transfer resistance, Cdl is the double layer
capacitance and Zw is the Warburg impedance.
The electrochemical active surface area of an electrode represents the area of
the functionalized electrode available for charge transfer. The active area of the
MWCNT-AuNPs functionalized electrode was found using the Randles-Sevčik
equation and was estimated to be 0.062 cm2, which was 1.24 times higher than that of
a bare electrode (Figure 4.3a). Furthermore, a linear relationship between the anodic
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and cathodic peak currents (R = 0.89 and 0.93 respectively) as a function of the square
root of scan rate verified that the redox process was diffusion-limited (Figure 4.3b and
c).

Figure 4.3. Cyclic voltammograms of a 5 mM K3[Fe(CN)6] solution in 0.1 M KCl for
a. Bare, MWCNT and MWCNT/Au functionalized electrodes. The higher surface area
provided by the nanomaterials was reflected by the higher cathodic and anodic currents.
b. Current response of a MWCNT/Au functionalized electrode at different scan rates c.
Calibration curve of peak current vs. square root of scan rate. Each experiment was
carried out in triplicate (n = 3), and the data is represented as mean ± SD. The linear fit
confirmed the diffusion-controlled reaction kinetics of the electrode.
4.3.2

Bienzymatic uric acid detection mechanism

Uricase is a peroxisomal enzyme that catalyzes the oxidation of UA to 5hydroxyisourate. The UOx functionalized electrode selectively oxidizes uric acid to
form hydrogen peroxide. H2O2 then serves as a substrate for HRP, where it gets reduced
as a result of the heterolytic cleavage of the oxygen-oxygen bond (Figure 4.4a). The
sensor quantifies the UA concentration by measuring the amount of H2O2 reduced at
the electrode through amperometric measurements at a certain working potential.
Control studies were performed to understand the functionality of the MWCNT-AuNPs
nanocomposite on the sensor response. The accelerated electron transfer facilitated by
the nanocomposite was reflected by the higher current response observed in the study
(Figure 4.4b). The MWCNT electrode showed 4.02 times increase in the current
density, while a 4.67 times increase was observed for the nanocomposite-casted
electrode in comparison to a bare electrode. The observed signal enhancement can be
attributed to the prevention of unfavorable lateral interactions between the enzymes on
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the electrode surface due to the MWCNT curvature.216 Additionally, the synergistic
non-covalent interaction between the MWCNTs and AuNPs provides an efficient
conducting interface for fast electron transfer.168,169 The improved signal in presence of
the nanocomposite can also be ascribed to the electrostatic interaction existing between
the UOx enzyme and AuNPs. The amine groups functionalized on the AuNPs impart a
positive charge on them, which then interacts with the negative charge of the UOx
leading to higher enzyme retention on the electrode surface. It was further seen that the
co-entrapment of the HRP and UOx enzymes within the MWCNT-AuNPs matrix
allowed for a faster electron transfer from the enzyme to the electrode. Control studies
showed that the current density improved by a factor of 2.0 on co-immobilization of
HRP (Figure 4.4b). This can be attributed to the electrostatic interactions between the
enzymes, that allows for easy diffusion of H2O2 to the active site of HRP site and
exchange electrons with it.
The sensor response of a MWCNT/Au/HRP/UOx functionalized electrode on
successive additions of UA was assessed next using chronoamperometric technique
(Figure 4.4c). An increase in the reduction current corresponded to an increase in the
UA levels. The linear response range of the sensor was found to be from 50 µM to 720
μM with a correlation coefficient of 0.97 (Figure 4.4d). The electrocatalytic activity of
the UA sensor exhibited a sensitivity of 42.55 nA μM−1 cm−2, and a lowest detectable
concentration of 5.54 μM which was better than the sensors reported till date (Table
4.1). The results demonstrated that the sensor can accurately measure UA in the
clinically relevant range; 200-750 μM. Sensor selectivity is a critical parameter to
determine the practical applicability of any sensor in a complex biofluid. The effect of
possible interferents (dopamine (DA), ascorbic acid (AA), hypoxanthine (HX) and
xanthine (XA)) present in the wound exudate on the sensor response was evaluated.
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The UA sensor showed good selectivity over other analytes at physiologically relevant
concentrations, with a comparatively higher increase (8.9%) in the current response
observed on addition of AA (Figure 4.5).
Further, the electrochemical characterization of the flexible sensors integrated
with the wearable SoC was carried out using chronoamperometry (Figure 4.4e). As
before, an increase in the current was observed as a function of increasing UA
concentration (Figure 4.4f). The linear response range of the sensor lied between 50
µM to 600 μM with a correlation coefficient of 0.95 (Figure 4.4g), and a sensor
sensitivity of 40.32 nA μM−1 cm−2. The lower current values obtained from the
wearable SoC can be attributed to the lower sensitivity offered by the miniaturized
potentiostat compared to a benchtop potentiostat. Also, the sensor response obtained
from the electronic system was noisier compared to the benchtop results since it doesn’t
include any signal filtering circuitry as integrated within a benchtop potentiostat. The
results were thus smoothed using a least-square method with a window of 5 data points.
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Figure 4.4. a. Schematic illustration of UA oxidation through a bi-enzymatic detection
mechanism b. Current response of a bare electrode modified with UOx, UOx electrode
modified with MWCNT, MWCNT/Au and MWCNT/Au/HRP to 250 μM UA, with the
latter exhibiting the highest current density c. Chronoamperometric sensor response of
the nanocomposite functionalized electrode (MWCNT/Au/HRP/UOx) as a function of
UA concentration d. Linear plot of cathodic current vs. UA concentration. The sensor
showed a linear range of 20 – 720 μM with a sensitivity of 42.55 nA μM−1 cm−2. Each
experiment was carried out in triplicate (n = 3) and the data is represented as mean ±
SD. e. Photograph of the wearable electronic system integrated with the flexible UA
sensors. The electronics was encased in a silicone elastomer (blue) to allow for easy
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conformation and prevent any patient discomfort f. Chronoamperometric sensor
response of the nanocomposite functionalized electrodes as a function of UA
concentration as recorded using the wearable electronic system g. Linear plot of
cathodic current vs. UA concentration obtained from the wearable electronic system.
The sensor showed a linear range of 50 – 600 μM with a sensitivity of 40.32 nA μM−1
cm−2. Each experiment was carried out in triplicate (n = 3) and the data is represented
as mean ± SD.
Table 4.1. Comparison of recently developed flexible sensors for electrochemical
detection of UA.
Sensor

Linear range

Sensitivity

Limit of detection

Carbon/UOx189

0-800 μM

4.375 μA mM−1cm−2

-

Graphene oxide207

0-200 μM

3.5 μA μM−1 cm−2

0.74 µM

Carbon

200-1000 μM

2.25 μA mM−1 cm−2

200 μM

50-720 µM

37.3 μA mM−1 cm−2

5.54 μM

black/potassium
ferricyanide/UOx214
CNT/Au/HRP/UOx
(This work)

Figure 4.5. Sensor selectivity of a MWCNT/Au/HRP/UOx functionalized electrode in
presence of potential interfering electroactive compounds present in the wound
exudate: DA (196 pM), XA (50 µM), HX (8 µM), and AA (50 µM). The results showed
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that the sensor response was minimally affected only in the presence of AA (8.9%
increase in sensor response) in a 50 µM UA solution. Each experiment was carried out
in triplicate (n = 3) and the data is represented as mean ± SD.
Enzymatic sensors are known to degrade with time due to enzyme denaturation
at elevated temperatures, affecting their stability and thus restricting their use under
physiological conditions.217 The long-term stability of the sensor was evaluated over a
period of 7 days under both laboratory and physiologically relevant conditions at a fixed
UA concentration (250 µM). While a 16.8% decrease in the sensor response was
observed for the sensor at room temperature (25oC), the sensor exhibited a 21.9%
decrease in the current at the body temperature (37oC) (Figure 4.6). At a further elevated
temperature of 40oC, the current decrease around 22.7%. The stable response offered
by the sensor under physiological conditions demonstrates its feasibility for utilization
as a wearable sensor for prolonged time periods. In the future, the sensor can be
calibrated to compensate for the changes in sensor response as a function of
temperature.

Figure 4.6. Sensor stability of a MWCNT/Au/HRP/UOx functionalized electrode under
room temperature (25oC), physiological conditions (37oC) and an elevated temperature
(40oC) over a period of 7 days. A degradation in sensor response was seen after 2 days,
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with the electrode subjected to an elevated temperature of 40oC showing the highest
degradation rate. Each experiment was carried out in triplicate (n = 3) and the data is
represented as mean ± SD.
4.4

Conclusion

This work reports a wearable sensing system consisting of an array of UA sensors and
a wearable electronic system for continuous monitoring of wound healing. Owing to
the mediator-free enzymatic approach, the sensor achieved stable (16.8% degradation
at 25oC, 21.9% at 37oC and 22.7% at 40oC) and accurate measurements over a period
of seven days for the UA sensor. A sensitivity of 42.55 nA μM−1 cm−2 enabled the
sensor to accurately measure uric acid in the clinically relevant range. An integrated
wound monitoring system was further fabricated by interfacing the flexible sensors to
custom-designed wearable electronics. An electrochemical characterization of the
system for UA detection revealed a sensitivity of 40.32 nA μM−1 cm−2. While the
system demonstrated a lower current response compared to the benchtop testing, no
significant decrease (~1.05 times) in the sensor sensitivity was observed. Given the rich
biochemical markers present in the wound exudate, the transition from traditional visual
inspection to electrochemical monitoring can provide a non-invasive real-time means
to monitor wound chronicity. A multiplexed sensing system can be used to provide
feedback to the system-on-chip in the future to allow for an on-chip real-time
calibration. Future work could also focus on in vivo studies on healing wounds to better
understand the correlation of UA concentration with wound healing.
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5
5.1

Uric Acid Detection on Flexible Sensors in a Dynamic Environment

Introduction

Continuous monitoring of relevant chemical biomarkers can provide valuable insights
on sudden changes in a person’s physiology. In comparison to intermittent assessments,
continuous monitoring can provide data that can help predict any future episodes.
Analysis of such data can help improve therapeutic efficacy and aid in better clinical
decision making. Several wearable sensors for continuous monitoring of metabolites
such as glucose,58,62,218,219, uric acid,153 and, lactate21,23,220 have been developed. The
estimation of these analytes in biofluids such as sweat is a potential alternative to bloodbased detection mechanisms. For example, direct correlations between glucose sweat
and blood concentrations have been established thus allowing a non-invasive
continuous means for monitoring of diabetes.221 Similarly, lactate in sweat has been
studied for monitoring physiological performance,21 cystic fibrosis222,223 and oxygen
level.224 Enzymatic sensors have especially been used, owing to their advantages of
continuous monitoring modality, sensitivity and selectivity. These sensors offer
significant advantages for longitudinal monitoring of health to provide actionable data
to the healthcare provider.
However, the deployment of these sensors in in vivo environments is faced with
several challenges. Owing to the great variations in the biofluid composition at an
individual level, there is always an ambiguity in the environment that the sensor is
placed in. As a function of the physiological processes, dietary habits, medication and
the underlying health condition of a person, the biofluid composition may change.
These changes in turn may affect the sensor response thus resulting in erroneous data.
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A fundamental drawback of enzymatic sensors is their sensitivity to the sensor’s
microenvironment. This becomes a major challenge when the sensor is placed in a
dynamic environment e.g., wound bed. The current wearable enzymatic sensors do not
take into account this dynamic variability offered by a wearable environment. The
conventional electrochemical sensor calibration is carried out assuming a steady-state
environment under controlled environmental conditions. However, in a complex
wearable environment, the environment does not necessarily assume a steady-state.
Only one study has been reported till date that incorporates a pH sensor in conjunction
with an enzymatic glucose sensor for real-time data correction.62 Thus, there is an
existing need to understand and model the sensor response with respect to the variations
in the environment for real-time calibration of the response to obtain accurate readings.
In this chapter, the effect of a dynamic environment offered by a wound on the
developed UA sensor has been investigated. The chapter focuses on the challenges
faced when a sensor is placed in an in vivo environment and how developing correlation
models can help reduce the error in the sensor response. The different parameters that
change as a function of wound healing were identified and varied according to the
expected physiological values. The identified parameters include, pH, temperature,
sample volume and evaporation. The effect of each parameter on the sensor response
was recorded and correlations were derived to develop mathematical models to correct
for the sensor response. The chapter further explores the effect of biofouling on the
sensor response. Two independent studies were conducted, with one correlating the
effect of physical adsorption of extracellular matrix components on the sensor response,
and second the effect of biofilm formation on the sensor surface.
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5.2
5.2.1

Experimental
Materials

Analytical grade UA (CAS No.: 69-93-2), LA (CAS No.: 50-21-5), sodium acetate
(CAS No.: 127-09-3), acetic acid (CAS No.: 64-19-7), sodium hydroxide (CAS No.
1310-73-2), hydrogen chloride (HCl, CAS No.: 7647-01-0), sodium hydroxide (CAS
No.: 1310-73-2), sodium bicarbonate (CAS No.: 144-55-8), sodium carbonate (CAS
No.: 497-19-8), sodium phosphate monobasic (NaH2PO4, CAS No. 10049-21-5) and
sodium phosphate dibasic (Na2HPO4, CAS No. 7558-7-4) were purchased from Sigma
Aldrich. Luria Bertani (LB) broth was purchased from Sigma Aldrich. All aqueous
solutions were prepared using DI water.
5.2.2

Dynamic variability study

The parameters considered for the study included pH, temperature, sample volume, and
evaporation. Buffer solutions of varying pH (5, 6, 7, 7.8, and 9) were prepared using
the relevant salts and the sensors were tested in the buffers for electrochemical
characterization. To study the thermal effect on the sensor response, the sensor was
immersed in an electrochemical cell with varying temperatures of 25oC, 30oC, 35oC,
and 40oC. To ensure uniform distribution of the sample over the sensor surface for the
volume study, a small circular piece of wound dressing (d = 5 mm) was placed covering
the three electrodes of the sensor. Different volumes (0.5, 1, 2, 3, 4, and 5 µl) of the UA
solution were then drop casted at the middle of the dressing to allow for uniform
diffusion of UA across the electrodes. Likewise for the evaporation study, a 10 µl
droplet of the UA solution was casted onto the dressing placed on the sensor and kept
at constant laboratory conditions of 25oC and 50% humidity. All the above studies were
carried using a 250 µM UA solution and performing chronoamperometry using a CHI230B potentiostat (CH Instruments, Inc.) at a bias potential of -0.6 V.

67

5.2.3

Biofouling study

The adsorption study was carried out by drop-casting different volumes of wound
exudates or skin sweat extracts collected from discarded wound dressings and drying
them at room temperature. Pseudomonas aeruginosa (PA01) strain was used for the
biofilm studies. A preculture was obtained by inoculating 10 ml of LB media with a
single colony of bacteria and the cultures were incubated overnight at 37°C at 200 rpm
on a shaker-incubator. The UA sensors were placed in a 200 µl of the prepared bacterial
inoculation over a period of 7 days. The cathodic current was measured continuously,
and the suspension was not disturbed over the entire course of study to prevent any
disruption of the biofilm. Scanning electron microscopy (SEM JEOL 6330) was carried
out to observe the biofilm growth over the sensor surface with respect to time.
5.3
5.3.1

Results and Discussion
Effect of pH and temperature

The pH and temperature of a wound bed are two parameters that are highly dependent
on the wound health.225,226 It has been established that the pH of a wound shifts from
alkaline (pH ~ 9) to acidic (pH ~ 4.7) as it heals.105 Moreover, development of bacterial
infections or inflammations in chronic wounds lead to an acidification and increased
temperature of the wound bed.144 Two of the major factors affecting the catalytic
activity of an enzyme are pH and temperature of the operational environment. A change
in these parameters can lead to conformational changes in the enzyme’s structure thus
affecting its catalytic activity. The pH and temperature range for the optimal
functionality of an enzyme varies with the enzyme used and the composition of the
matrix it is placed in. The current response of an enzymatic sensor may thus vary as a
consequence of these structural changes in the enzyme resulting in a confounded
response. Furthermore, protonation-deprotonation in the biofluids as a function of
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changing pH can result in a change in the ion transport, directly affecting the sensor
response.227,228
The optimal pH range defined for the uricase enzyme is between 7.5 – 8.5. We
investigated the effect of pH (5 - 9) on the sensor response and it was seen that the
highest response was recorded at a pH of 7.8, while the current decreased for both more
acidic and alkaline environments (Figure 5.1). Earlier studies have shown that UOx
precipitates at pH levels lower than 8.0 resulting in a considerable loss of activity,
which can be attributed to the observed lower sensor response.217 Hence, measurement
of sensor’s environmental pH in conjunction with UA measurements is required to
correct for the UA sensor response.

Figure 5.1. Change in UA sensor response of a MWCNT/Au/HRP/UOx functionalized
electrode as a function of varying pH (5, 6, 7, 7.8, and 9). Highest sensor response was
observed at a pH of 7.8. Each experiment was carried out in triplicate (n = 3) and the
data is represented as mean ± SD.

To that effect, a flexible pH sensor was designed and tested to allow for simultaneous
wound pH measurements. The working principle of the sensor was based on the
protonation of a conductive polymer, polyaniline. As a result of change in the pH, the
nitrogen atoms consisting the backbone of polyaniline protonate/deprotonate on
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interacting with the protons and the hydroxide ions in the solution. This change can be
captured by measuring the resulting potentiometric changes. The response curve of the
constructed pH sensor is shown in Figure 5.2a, and the sensitivity of the sensor was
calculated to be 81.63 mV pH-1 (Figure 5.2b).
a.

b.

Figure 5.2. a. open circuit potential response of a pH sensor as a function of varying pH
(5, 6, 7, 7.8, and 9). b. Calibration curve of the pH sensor. The sensitivity of the sensor
was found to be 81.63 mV pH-1.

Mathematical correlation models establishing the relationship between the UA
response and change in pH can help in obtaining accurate sensor data. In order to
achieve that, UA sensor calibration curves were recorded in different pH buffers
(Figure 5.3a), and the data was further utilized to develop a regression model (Equation
5.1).
𝐶𝑢𝑟𝑟𝑒𝑛𝑡 = (−0.0026 ∗ 𝐶𝑜𝑛𝑐. ) − (0.1924 ∗ 𝑝𝐻) − 1.6251

(Equation

5.1)
Next, pH and UA measurements were made simultaneously, and the model was
used to correct for the sensor response. The calibration equation developed at a pH of
7.8 was used for standard UA calculations, and the UA level was calculated to be 150
µM (Figure 5.3b). On calculating the UA response using the model, it was observed
that the model did not result in accurate estimation of the actual UA level (i.e. 200 µM),
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but the error was reduced from ±21% to ±7% (Figure 5.3b). In the future, an extensive
study will be carried out with more sensor data to improve the accuracy of the
developed model. Furthermore, more complex mathematical model needs to developed
taking all the parameters into consideration at the same time.

a.

b.

Figure 5.3. a. Calibration curves of the UA sensor in buffers of varying pH (5, 6, 7, 7.8,
and 9). The highest current density and sensitivity was found at a pH of 7.8. Each
experiment was carried out in triplicate (n = 3) and the data is represented as mean ±
SD b. Simultaneous measurement of pH and UA levels. The black curve shows the
estimated UA concentration on using the standard calibration curve obtained at pH 7.8
and the red curve shows the measured pH. The blue curve represents the corrected UA
concentration as obtained from the developed regression model by taking the
environmental pH (7.0 in this case) into consideration.

Similarly, the thermostability of a wearable sensor is considered an important and
useful criterion especially for continuous monitoring applications. Any localized
changes in the blood flow rate in the wound milieu can lead to an increase or decrease
in the local temperature.139,229A decrease in the protein helical content and complete
loss of tertiary structure at elevated temperatures results in the inactivation of UOx
enzyme.217 The rate of enzyme degradation at elevated temperatures is reported to be
higher than at room temperature. The sensor response is thus expected to degrade at a
higher rate at elevated temperatures. The change in sensor response after subjecting the
sensor to elevated temperatures was recorded, and a 10% lower current was observed
at 400C compared to a sensor placed at 250C (Figure 5.4).
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Figure 5.4. Change in UA sensor response of a MWCNT/Au/HRP/UOx functionalized
electrode as a function of temperature (25oC, 30oC, 35oC, and 40oC) of the sensor
environment. A linear degradation in the sensor response was observed with an increase
in the temperature of the sensor’s environment. Each experiment was carried out in
triplicate (n = 3) and the data is represented as mean ± SD.

Similar to pH, calibration curves for the UA sensor were obtained at different
temperatures. It was seen that the sensor response and the sensor sensitivity at higher
temperatures was lower, which can be attributed to the deactivation of the enzyme
(Figure 5.5a). Using the obtained data, a regression model was developed establish a
correlation between the sensor’s environmental temperature, sensor response and the
corresponding UA concentration (Equation 5.2).
𝐶𝑢𝑟𝑟𝑒𝑛𝑡 = (−0.0018 ∗ 𝐶𝑜𝑛𝑐. ) + (0.0283 ∗ 𝑡𝑒𝑚𝑝) − 4.0492
5.2)
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(Equation

a.

b.

Figure 5.5. a. Calibration curves of the UA sensor in buffers of varying temperatures
(25oC, 30oC, 35oC, and 40oC). The highest current density and sensitivity was found at
a temperature of 25oC. Each experiment was carried out in triplicate (n = 3) and the
data is represented as mean ± SD b. Simultaneous measurement of temperature and UA
levels. The blue curve shows the estimated UA concentration on using the standard
calibration curve obtained at temperature 25oC and the red curve represents the
measured temperature. The black curve represents the corrected UA concentration as
obtained from the developed regression model by taking the environmental temperature
(30oC in this case) into consideration.

The developed model was further validated by making simultaneous temperature and
UA measurements. As seen from Figure 5.5b, the model estimated the UA level with
an error of ±3%. As mentioned earlier, a larger sensor dataset will aid in further
improvement of the model accuracy. The obtained correlations between the pH,
temperature and sensor response can thus be utilized to correct for the calculated UA
levels. Moreover, these models can be used in the future to develop an edge IoT-based
approach to correct for the sensor response in real-time.
5.3.2

Effect of sample volume and evaporation

One of the fundamental requirements of an electrochemical sensor is that a sufficient
amount of sample volume is required to facilitate ion transport between the electrodes.
Low exuding chronic wounds pose a major challenge for electrochemical
measurements owing to insufficient wetting of the sensor to produce accurate response.
The effect of sample volume on the sensor response is thus necessary to be assessed to

73

determine the volume required for optimal sensor functioning. In a real setting, a
dressing is placed in between the sensor and wound to prevent any occlusion effects on
the wound. Thus, a small piece of wound dressing (d: 5 mm) was placed over the UA
sensor and different volumes of the UA solution were drop casted to allow for uniform
distribution of the solution over the sensor surface. Results indicated a 6.8% decrease
in the current response from 5 µl to 0.5 µl (Figure 5.6a), while current response for 5
µl or above was seen to be the same. While the sensor was functional at a low volume
of 0.5 µl, the results implied that a minimum sample volume of 5 µl was required for
accurate UA measurements. Chronic wounds are typically not expected to be
completely dry and thus the study established the practical applicability of the sensor
for UA measurement in low exuding wounds as well.

Figure 5.6. a. Change in UA current response of a MWCNT/Au/HRP/UOx
functionalized electrode as a function of sample volume (0.5 µl, 1 µl, 2 µl, 3 µl, 4 µl, 5
µl, 10 µl, 30 µl and 50 µl). The minimal sample volume for accurate sensor functioning
was found to be 5 µl. Each experiment was carried out in triplicate (n = 3) and the data
is represented as mean ± SD b. Change in UA current response of a
MWCNT/Au/HRP/UOx functionalized electrode to a 10 µl UA droplet (250 µM)
evaporating with time under constant environmental conditions (25oC and 50% RH).
Zone 1 represents the evaporating stage of the droplet, with an increase in the current
observed due to the evaporation of the solvent. Zone 2 shows an insufficient coverage
of ions over the electrode surface due to evaporation, resulting in a zero current.
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Traditionally, wet-to-dry wound dressings are used for dressing chronic wounds since
maintaining optimal moisture conditions in a wound is vital. They are designed to
maintain a humid environment at the wound site to increase the rate of epithelialization
while removing the excess wound exudate. These dressings thus continually evaporate
the wicked exudate from the dressing to allow for continued absorption for extended
periods of time. While sensing in low sample volumes is challenging due to insufficient
sensor wetting, evaporation of these low volumes further adds to the sensing
complexity. Additionally, the substrate properties of the wound dressings also play a
major role in sample transport. The mass transport dynamics of the UA from the wound
environment to the sensor surface is primarily governed by the wicking properties of
the dressing. Similar to the volume study, in order to study the effect of evaporation on
the sensor response, a 10 µl droplet of UA solution (250 µM) was dropped onto a piece
of dressing (d:5 mm) placed on the sensor. The solution was allowed to evaporate under
maintained environmental conditions of 25oC and 50% RH while monitoring the
current response in real-time. As the sample evaporates, an increase in the current
response was observed (Zone 1) due to an increase in the ionic concentration associated
with the decreasing sample volume (Figure 5.6b). Subsequently, owing to the complete
evaporation of the sample volume after 33 min, insufficient coverage on the sensor
surface resulted in a zero-current response (Zone 2). The changes in the ion
concentrations in the sample as a result of evaporation thus governs the sensor response
and a theoretical model is desirable to map these changes in real-time. Such a model
will require to take the substrate properties and UA transport mechanics into
consideration to accurately predict the sensor response.
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5.3.3

Adsorption of wound debris on active area

Wound exudate is a complex biofluid consisting of proteins, extracellular matrices,
blood components and several electrolytes.230,231 The adsorption of wound debris over
the active area of the sensor can lead to the phenomenon of electrode fouling; which
can be referred to as the accumulation of unwanted material on the surface, detrimental
to the sensor performance. Sensor fouling is one of the critical factors in wound
monitoring sensors that can affect the measurements under a continuous time period
reducing the reliability of the sensors. When the sensor is placed directly over the
wound bed, the different components of the wound exudate can adsorb over the
electrode and may start crosslinking. This can result in blocking of a substantial portion
of the active area, thereby fouling the electrode and resulting in a low sensor recovery.
The change in UA sensor response with fouling was characterized as a function of the
dried volume of wound exudate or biofluid extract from perilesional skin. Figure 5.7
illustrates the percentage decrease in current observed over 5 sequential depositions of
buffer in absence of biofluid, wound exudate or biofluid extract from perilesional skin.
While in the latter two cases, a continuous attenuation of the current response was
observed with increasing volume, the degree of fouling of the sensor with adsorbed
wound exudate was seen to be 1.5 times higher than the sensor with adsorbed biofluid
extract from perilesional skin. The sensor with adsorbed biofluid from perilesional skin
showed a similar current degradation rate as the sensor with no biofluid adsorbed. The
peak current was observed to reduce by 68.6% after 5 depositions of the wound exudate,
while only a 48.5% reduction was seen for the biofluid from perilesional skin adsorbed
sensor. After three depositions, the diffusion of UA from the blk solution to electrode
surface becomes extremely difficult as reflected in the 20% decrease in the sensor
response. While sweat is a complex biofluid, a higher heterogeneity and matrix
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complexity is expected in a wound exudate which in turn results in a greater response
degradation. The lower degradation rate of the sensor adsorbed with only biofluid
extract from perilesional skin can enable the sensor application for long-term
monitoring purposes. These results can serve as models for the design and calibration
of sensors for accurate response estimation.

Figure 5.7. Change in current response of the UA sensor as a function of the volume of
the buffer (0 µl, 2 µl, 4 µl, 6 µl, 8 µl and 10 µl) in the absence of biofluid (1), wound
exudate (2) or perilesional skin extract (3) dried on the nanocomposite-enzyme
functionalized electrodes. The higher degradation rate of electrode fouling with wound
exudate showed the presence of non-specific adhering compounds present in the
biofluid matrix.

Such sensors when placed in an in vivo environment especially on a wound bed,
produce low recovery values compared to conventional testing, which can be ascribed
to the demonstrated fouling effect. A sensor placed in the wound vicinity rather than
directly over the wound bed can help reduce the electrode fouling issues. Hence, the
measurement of UA levels in the biofluid from perilesional skin may present a
promising sensing approach more suitable for continuous wound monitoring.
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5.4

Conclusion

In this work, the effect of dynamic variability in the wound biofluid on UA sensor
response has been investigated. The parameters under consideration included pH,
temperature, sample volume, evaporation, and sensor fouling. In particular, the
dynamic variability of these parameters with different wound healing stages is
discussed and their effect on the UA sensor response is assessed. The sensor response
was seen to be highest at a pH of 7.8, with a decrease in the response observed for both
a more alkaline (pH > 8.0) and a more acidic environment (5 > pH > 8.0). The results
agreed with the general optimal pH range for the uricase enzyme to be known between
7.5 and 8.5. Similarly, a direct correlation was observed between the sensor response
and the operational temperature. A linear decrease in the current was seen as a function
of increasing temperature. The results confirmed that as a consequence of these
parameters temporally changing in the wound environment, the sensor response will be
altered. The established correlations were utilized to develop mathematical models to
correct for the real time sensor response obtained when placed in an in vivo environment
and validated through simultaneous measurements. An optimal sample volume of 5 µl
was determined from the sample volume studies. The current was seen to decrease as a
function of decreasing volume owing to the insufficient fluid coverage over the
electrodes. Further, as result of evaporation the UA concentration was seen to increase
reflected as an increase in the current, with zero current observed subsequently due to
complete evaporation of the sample volume. Deposition of extracellular proteins on the
sensor surface resulted in a degraded sensor response. Physical adsorption of the wound
exudate on the sensor surface was seen to result in an impeded UA diffusion to the
sensor surface. The results show that changes in environmental parameters of the
wound such as, pH and temperature need to be accounted for, in order to obtain accurate
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UA sensor response. An integrated platform monitoring these parameters
simultaneously may allow for real-time calibration of the UA sensor to obtain reliable
in vivo measurements.
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6
6.1

Toxicity Assessment of Wearable Wound Sensor and its Constituents
Introduction

In an emerging age of wearable medical devices, the health risk from exposure to the
active materials incorporated in these devices is a topic of concern. Wearable sensors
that monitor biological activity, disease, and metabolism, integrate biochemical sensors
in their sensor suite that interface directly with the human body. These biochemical
sensors are comprised of a combination of materials to sense the target biological
analytes. These materials can be classified into different categories: active sensing
materials or reaction catalysts, electron mediators, binders, and crosslinkers. Owing to
the unique properties offered by nanoparticles, they are increasingly being used in
biochemical sensors as reaction catalysts for improving sensor sensitivity.
Biorecognition elements such as enzymes, antibodies, and aptamers fall under the
active sensing materials category. While these biorecognition elements may not pose
any major biocompatibility issues, questions have been raised about the
biocompatibility of several nanoparticles. Previous studies have shown that the toxicity
of nanoparticles is dependent on several factors, such as their material, size, shape,
stabilizing agent, and concentration. For example, a previously reported study on
screening of one such active sensing material, silver nanoparticles (AgNPs), showed
that they are toxic to both dermal and epidermal cells at high concentrations.232,233 It
was further shown that given the smaller size of Ag ions, they induced higher toxicity
as compared to AgNPs. Another study, on AgNPs, revealed that both the morphology
and the stabilizing agent used in nanoparticle synthesis influenced their cytotoxic
behavior.234,235 Exposure to certain nanoparticles (NPs) can also lead to morphological
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changes in the cellular structure by altering the shape of the cells to fusiform.236–238
Carbon nanotubes have been extensively used as an electron mediator and have been
reported to exhibit a time and dose-dependent toxicity.239 A study showed that altering
the surface chemistry of the carbon nanotubes leads to morphological changes in the
cell.240 Studies have further shown that some materials not only affect the cell viability
but also lead to damage of subcellular organelles, like mitochondria and lysosomes.
The damage to these subcellular organelles leads to increased levels of reactive oxygen
species (ROS). Mitochondrial disruption has been seen as a result of cellular uptake of
silica (SiO2),241 iron (Fe) NPs242 and, multiwalled carbon nanotubes (MWCNTs)243.
Studies have also shown that a high concentration of NPs can decrease the cellular ATP
content, leading to a damaged mitochondrion.244 Another study showed that the surface
charge on gold nanoparticles (AuNPs) regulated their apoptotic inducing nature,
wherein a charged AuNP expressed a higher number of apoptotic cells compared to an
uncharged NP.237 Similarly, several other NPs such as TiO2, CuO, and AgNPs have
been shown to induce apoptosis at certain concentrations.245–247 The above-mentioned
studies thus suggest that assessing the toxicity of any material being used in these
wearable devices is of utmost importance.
One such example of wearable monitoring sensing systems is wearable wound
sensors, which incorporate biochemical sensors that are placed in direct contact with
the tissue and wound fluid. An open wound exposes the underlying human tissue,
potentially subjecting it directly to the sensor and the active materials integrated within
the sensor. Thus, the leaching of any toxic material into an open wound may induce an
inflammatory response resulting in a hindered healing process. Therefore, toxicological
screening of the active materials used in these wound sensors is highly imperative. In
vitro human cell culture studies have emerged as an excellent tool for carrying out
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preliminary toxicity studies. Based on the target human organ, a relevant cell line can
be chosen to determine the toxic effects of the test material(s) under in vitro conditions.
For instance, keratinocytes and fibroblasts can be used as model cell lines to understand
the effect of sensing materials on open wounds. Keratinocytes constitute 90% of the
human epidermis, with their primary function being protecting the skin against any
environmental damage. They play a critical role in wound healing by participating in
the epithelization process. In response to an injury, keratinocytes proliferate and
migrate to form the epidermal barrier layer of the skin.248 On the other hand, fibroblasts
are the main connective tissue cells present in the body. They play a major role in the
proliferation and remodeling stage of wound healing. These cells create a new
extracellular matrix (ECM) and collagen structures that provide support for cell
proliferation, thus facilitating wound contraction.249 Any material toxic to these
keratinocytes and fibroblasts may lead to significant impairing of the wound healing
process. Thus, for this work, keratinocytes and fibroblasts were cultured in vitro to
study the toxicity profiles of the active sensing materials used in our sensor. Through
these studies, a comprehensive understanding of the toxicity effects and the ability of
the cells to tolerate active materials can be developed to build biocompatible sensing
systems.
In this chapter, the toxicity profile of the wound monitoring enzymatic sensor
is investigated on human keratinocytes and fibroblasts. The sensor incorporates a
combination of active sensing materials (biorecognition elements) and reaction
catalysts (nanomaterials).250,251 To assess the toxicity profile, the individual active
materials and the fabricated sensor were investigated at different concentrations using
the gold standard MTT assay. Furthermore, the mitochondrial and apoptotic effects of
these materials was investigated. This was achieved by conducting in vitro assays on
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an epidermal cell line (HaCaT) and a dermal cell line (HDFa). The chapter details the
time and concentration-dependent changes in the cell viability, mitochondrial activity,
and apoptotic activity of the cells on treatment with the entire wound sensing system.

6.2
6.2.1

Experimental
Materials and Apparatus

AuNPs (ø: 20 nm) and MWCNTs (9.5 nm × 1.5 μm) were purchased from Sigma
Aldrich, USA. Uricase enzyme, horseradish peroxidase (HRP) enzyme, 3-(4, 5dimethyl thiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT), and dimethyl sulfoxide
(DMSO), Dulbecco’s Phosphate Buffered Saline (DPBS) were purchased from Sigma
Aldrich and ThermoFisher Scientific, USA respectively. alamarBlue was obtained from
ThermoFisher Scientific, USA. Cell culture media, antibiotics, and other cell culture
reagents were purchased from Gibco, ThermoFisher. The human epidermal
keratinocyte cell line (HaCaT) was kindly provided by Dr. Marcus Cooke at the FIU
Department of Environmental Health Sciences, Miami, Florida, and dermal fibroblast
cell line (HDFa) was purchased from ATCC.
Fluorescence microscopy of the cells was carried out using a fluorescent
microscope (Axio Scope.A1, Zeiss). The fluorescence intensity measurement was
performed using a Synergy HTX Multi-Mode microplate reader (BioTek Instruments,
USA). A Multiskan™ FC microplate reader (ThermoFisher Sc., USA) was used for
absorbance measurements.
6.2.2

Exposure of keratinocytes and fibroblasts to the treatment groups

Cells (keratinocytes and fibroblasts) were maintained in Dulbecco's Modified Eagle's
Medium (DMEM) and supplemented with a 10% fetal bovine serum (FBS) and 1%
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antibiotics (penicillin/streptomycin). The cells were maintained in an atmosphere of 5%
CO2 at 37oC and 70% RH until 70% confluency and then introduced to the different
treatment groups. Five different treatment groups were selected for our study namely,
gold nanoparticles (AuNPs), multiwalled carbon nanotubes (MWCNTs), uricase
enzyme (UOx), horseradish peroxidase enzyme (HRP), and the biosensor. The toxicity
profile of these treatment groups was assessed at different concentrations and different
treatment periods as provided in Table 6.1. Three concentrations of each treatment
group were tested for their toxicity at two different time points: 12 and 24 h.
Concentration C2 in the table represents the concentrations of the materials as
immobilized on the sensor, and C1 and C3 were taken as ten times lower and higher
than C2.
Table 6.1. The treatment groups and the respective test concentrations used for
assessing their cytotoxicity on epidermal (HaCaT) and dermal (HDFa) cell lines. In the
table C1, C2, C3 represent concentration, and G1, G2, G3, G4, and G5 represent the
test groups. Concentration C2 in the table represents the concentrations of the materials
as immobilized on the sensor, and C1 and C3 were taken as ten times lower and higher
than C2.
Treatment group

Test concentrations

G1: AuNPs

C1:0.5, C2:5 and C3:50 µg/ml

G2: MWCNTs

C1:0.001, C2:0.01 and C3:0.1 µg/ml

G3: UOx

C1:0.2, C2:2 and C3:20 µg/ml

G4: HRP

C1:0.02, C2:0.2 and C3:2 µg/ml

G5: Biosensor

C1: Unfunctionalized sensor
C2: Functionalized sensor (AuNPs: 5
µg/ml, MWCNTs: 0.01 µg/ml, UOx: 2
µg/ml and HRP: 0.2 µg/ml)
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6.2.3

Assessment of cell toxicity using MTT assay

The cell viability of keratinocytes and fibroblasts exposed to the different treatment
groups was probed using the MTT assay. This assay is a colorimetric assay widely used
for assessing cell viability. In living cells, the yellow-colored tetrazole gets converted
to purple formazan crystals. The insoluble formazan crystals are then dissolved using a
solubilization solution (DMSO) and the color intensity of the solution can be quantified
at 570 nm using a plate reader to determine the cell viability.252 The NAD(P)Hdependent oxidoreductase enzymes present in the cytosol of the cell catalyze this
reaction, thus reflective of the cellular activity.253 To evaluate the toxicity profile of the
treatment groups IC70 values were taken into consideration in our study.254
HaCaT/HDFa cells were seeded in a 96-well plate with 10,000 cells per well
and cultured until 70% confluency was reached. Subsequently, the original medium
was replaced by medium containing a treatment group at different concentrations and
incubated for varying time points (12 and 24 h). A volume of 20 μl (5 mg ml–1) of MTT
was added to each well and incubated at 37°C for 4 h. Finally, the medium was removed
and 200 μl of dimethylsulfoxide (DMSO) was added to each well. Absorbance was
measured at 570 nm using a microplate reader. Cells not exposed to any treatment group
served as a set of negative control for the experiments and cells exposed to 70% ethanol
for 15 min served as a set of positive control.255,256
6.2.4

Assessment of cell viability using live/dead assay

To assess the cell viability through imaging as a result of exposure to the different
treatment groups, time-lapse fluorescent microscopic images were captured. A
live/dead viability/cytotoxicity kit (ThermoFisher Sc., USA) was used for tagging the
live/dead cells. Calcein AM and ethidium homodimer are the two dye molecules used
to indicate live and dead cells, respectively. In live cells, calcein AM diffuses within
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the cytoplasm via the plasma membrane and hydrolyzes to produce green fluorescent
calcein.257 This reaction is the result of the esterase activity of cells trapped within the
cytosol. If the cell is dead, ethidium homodimer, a membrane impermeant dye molecule
intercalates to the free nucleic acids indicating a compromised cell membrane integrity
by exhibiting a red fluorescence.258
HaCaT/HDFa cells were seeded in a 96-well plate with 10,000 cells per well
and cultured until 70% confluency was reached. Subsequently, the original medium
was replaced by medium containing the treatment group at different concentrations and
incubated for varying time points (12 and 24 h). After exposure to the treatment groups,
the cells in the 96-well plate were incubated with the fluorescent dyes at optimal
concentrations in dark at 25°C for 30 min following which the cells were imaged under
a fluorescent microscope at 20x magnification of the objective lens. Cells not exposed
to any treatment group served as a set of negative control for the experiments and cells
exposed to 70% ethanol for 15 min served as a set of positive control.259,260 Five images
were taken per well to obtain statistically relevant data. The obtained images were
further used to calculate the cell viability by manually counting the number of green
and red cells in each image.
6.2.5

Assessment of mitochondrial activity

The mitochondrial activity of the cells exposed to the treatment groups was investigated
using the resazurin assay. The cellular dehydrogenases present inside the mitochondria
reduce resazurin (pink color) to form resorufin (red color) resulting in a colorimetric
change. The resulting color intensity can then be correlated to the number of respiring
cells (Eq. 1). The reduction of resazurin is carried out by different oxidoreductase
enzymes present within the mitochondria, thus indicating the cellular mitochondrial
activity.261
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𝑟𝑒𝑠𝑎𝑧𝑢𝑟𝑖𝑛𝑜𝑥 + 2𝐻 + + 2𝑒 − ↔ 𝑟𝑒𝑠𝑎𝑧𝑢𝑟𝑖𝑛𝑟𝑒𝑑

Equation 1

HaCaT cells/HDFa cells were seeded in a 96-well plate with 10,000 cells per
well and cultured until 70% confluency was reached. Subsequently, the original
medium was replaced by medium containing the treatment group at different
concentrations and incubated for 24 h. Alamar Blue was added (10% final volume) to
the treated cells and incubated at 37°C. Following an incubation time of 4 h, the
absorbance levels were measured using a microplate reader at 570 nm excitation and
600 nm reference wavelengths. A subtraction analysis of the dual wavelength was
performed to obtain accurate measurements. Cells not exposed to any treatment group
served as a set of negative control for the experiments and cells exposed to carbonyl
cyanide m-chlorophenyl hydrazone (CCCP) served as a set of positive control.262–264
6.2.6

Assessment of apoptotic activity

The apoptotic activity of the cells exposed to the treatment groups was investigated
using the Caspase 3/7 assay. Caspase-3 and caspase-7 are major and early indicators of
apoptosis; these caspases are activated following the leakage of cytochrome C from the
mitochondria.265 The Caspase-3/7 assay is a fluorogenic substrate, consisting of a four
amino acid peptide (DEVD) conjugated to a DNA binding dye. On activation of
Caspase-3/7 in the apoptotic cell, the DEVD peptide is cleaved and the dye binds to
DNA, producing a bright fluorescence response.266
HaCaT cells/HDFa cells were seeded in a 96-well plate with 10,000 cells per
well and cultured until 70% confluency was reached. Subsequently, the original
DMEM was replaced by DMEM containing the treatment group at different
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concentrations and incubated for 24 h. Next, the medium was removed and 100 µl of
Caspase 3/7 reagent (5 µM) was added to the wells. Following this, the cells were
incubated at 37°C for 30 min and fluorescence was measured at excitation/emission
wavelengths of 502/530 nm. Cells not exposed to any treatment group served as a set
of negative control for the experiments and cells exposed to 10 µM camptothecin for 8
h served as a set of positive control.267,268
6.3
6.3.1

Results and Discussion
Assessment of cell toxicity using MTT assay

As discussed in the earlier chapters, the wound monitoring sensor used in this study
was fabricated using screen-printing and is constituted of active materials that include
AuNPs, and MWCNTs as electron transport substrates, and UOx, and HRP as the
biorecognition elements. In vitro testing has been widely employed as the first step in
assessing the biocompatibility of a certain material. The cytotoxicity of the above
materials was determined using an MTT assay, to understand their effect on dermal and
epidermal cells.
For both the cell lines, a time and dose-dependent decrease in cell viability was
seen when treated with AuNPs. It was observed that at a lower concentration (effective
concentration on the sensor, < 5 µg/ml) the cell viability was higher than 70% (IC70),
confirming no cytotoxic effect (Figure 6.1a and Figure 6.2a). Beyond 5 µg/ml
concentration of AuNPs, the cell viability decreased <50%, probably due to the
generation of reactive oxygen species or toxicity of AuNPs269 (Figure 6.1a and Figure
6.2a). The cytotoxic nature of the nanoparticles at higher concentrations can also be
attributed to the surfactants used for stabilizing the NPs.270 Contrary to AuNPs, in the
case of MWCNTs no cytotoxic nature for both the cell lines was observed. At
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concentrations > 0.1 µg/ml, the cell viability was observed to be >80% after exposure
for 24 h (Figure 6.1b and Figure 6.2b). The biocompatible nature of MWCNTs is the
reason they have been widely employed as catalysts especially in wearable
applications.271,272 As opposed to single-walled CNTs, multi-walled CNTs have been
seen to exhibit no cytotoxic effects. Cell viability was observed to be 80% on treatment
with UOx at the highest concentration for both the cells after a 24 h exposure. The
higher cell viability (>70%) indicated that both the enzymes were non-toxic (Figure
6.1c,d and Figure 6.2c,d). The slight decrease in the viability on exposure to the UOx
enzyme may be attributed to the presence of uric acid in the bovine serum present in
the growth media. The production of hydrogen peroxide (H2O2) produced by the
enzymatic reaction between the two materials (UOx and UA) may result in cell viability
reduction.273 It is well known that high concentrations of H2O2 result in cytotoxic
behavior.274 Since our results show reduced cell viability at higher UOx concentrations,
it could be inferred as a result of increased H2O2 production.

Figure 6.1. Cytotoxicity assessment of the active materials and sensor on the epidermal
cell line, HaCaT. The x-axis represents the concentration of the test compound (µg/ml)
and the y-axis represents the cell viability (%). Bar graphs depict the cell viability
assessed by MTT assay in response to the treatment group a. AuNPs, b. MWCNTs, c.
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UOx, d. HRP and e. sensor at varying concentrations and time points. All the data is
depicted as mean ± SD from three (n = 3) independent experiments.

Figure 6.2. Cytotoxicity assessment of the active materials and sensor on the dermal
cell line, HDFa. The x-axis represents the concentration of the test compound (µg/ml)
and the y-axis represents the cell viability (%). Bar graphs depict the cell viability
assessed by MTT assay in response to the treatment group a. AuNPs, b. MWCNTs, c.
UOx, d. HRP and e. sensor at varying concentrations and time points. All the data is
depicted as mean ± SD from three (n = 3) independent experiments.
Since the sensor utilizes screen-printed inks for its fabrication, we hypothesized
that the inks may result in leaching of material which may induce a cytotoxic response.
Thus, to evaluate the toxicity profile of the sensor/ink, we carried out an MTT assay on
an unfunctionalized and functionalized sensor. The cell viabilities for an
unfunctionalized sensor were recorded to be 85% and 98% for epidermal and dermal
cell lines respectively (Figure 6.1e and Figure 6.2e). The higher % viability (>70%)
suggested insignificant toxicity to either of the cells. On the other hand, cell viabilities
of 83% and 82% were observed for a functionalized sensor after a 24 h treatment of the
cells to the functionalized sensor for epidermal and dermal cell lines respectively
(Figure 6.1e and Figure 6.2e). This slight decrease in the viability observed for the
functionalized sensor can be owed to the immobilized active materials. It was observed
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that the cell viability for the functionalized sensor was higher than that for the individual
materials. This cell viability can be attributed to the enzyme casting over the
nanomaterials. The enzyme matrix acts as a biocompatible coating over the biosensor
resulting in reduced leaching of the sensor materials. Thus, our results (i) confirm that
all the active materials used in the sensor exhibit no significant toxicity with cell
viabilities being above 70% for the concentrations as used in the sensor and (ii) suggest
that a functionalized sensor elicits only marginal effects on epidermal and dermal cell
proliferation and viability.
6.3.2

Assessment of cell viability using live/dead assay

Fluorescent microscopy was carried out to assess the cell viability on exposure to the
different treatment groups (AuNPs, MWCNTs, UOx, HRP, and sensor) at varying
concentrations and time points (Figure 6.3 and Figure 6.4) for the dermal and epidermal
cell lines. A live/dead staining protocol was used which distinguishes cells with a
compromised cell membrane by tagging them red. Cells (HDFa and HaCaT) when
treated with AuNPs at a concentration >5 µg/ml for 24 h revealed a higher number of
dead cells, indicated by the red fluorescent dye (Figure 6.3b and Figure 6.4b) as
compared to the negative control (Figure 6.3a and Figure 6.4a). In the case of MWCNT,
UOx, and HRP enzyme a high number of live cells were observed for both HDFa and
HaCaT cells (Figure 6.3c,d,e and Figure 6.4c,d,e). However, epidermal cells were
observed to be more sensitive compared to the dermal cells (Figure 6.4c, d and e). In
addition, treatment of both the cell lines with an unfunctionalized and functionalized
sensor showed a lesser number of dead cells. As mentioned before, this can be attributed
to the protective layer offered by the enzyme matrix over the AuNPs and MWCNTs
(Figure 6.3f and Figure 6.4f). To corroborate the cell viability obtained from the MTT
assay, image analysis was carried out using the captured fluorescence images by
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manually counting the number of live and dead cells to calculate the cell viability
(Appendix 1).
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Figure 6.3. Live/Dead stained fluorescent images of HDFa (fibroblasts) when exposed
to the different treatment groups. Representative fluorescent images captured after
treatment with a. Control group (cells exposed to no treatment served as the negative
control and the cells treated with 70% ethanol for 15 min served as the positive control)
b. AuNPs (0.5, 5 and 50 µg ml-1), c. MWCNTs (0.001, 0.01 and 0.1 µg ml-1), d. UOx
(0.0005, 0.005 and 0.05 U ml-1), e. HRP (0.0005, 0.005 and 0.05 U ml-1) and the f.
sensor (functionalized and unfunctionalized), respectively at different time points (12
h and 24 h). In the images, the green color (calcein dye) represents the live cells while
the red color (ethidium homodimer dye) represents the dead cells. Each experiment was
carried out in triplicate (n=3) and five images were captured per well to account for
spatial distribution. Magnification: 20x, Scale bars: 50 μm.
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Figure 6.4. Live/Dead stained fluorescent images of HaCaT (keratinocytes) when
exposed to the different treatment groups. Representative fluorescent images captured
after treatment with a. Control group (cells exposed to no treatment served as the
negative control and the cells treated with 70% ethanol for 15 min served as the positive
control) b. AuNPs (0.5, 5 and 50 µg ml-1), c. MWCNTs (0.001, 0.01 and 0.1 µg ml-1),
d. UOx (0.0005, 0.005 and 0.05 U ml-1), e. HRP (0.0005, 0.005 and 0.05 U ml-1) and
the f. sensor (functionalized and unfunctionalized), respectively at different time points
(12 h and 24 h). In the images, the green color (calcein dye) represents the live cells
while the red color (ethidium homodimer dye) represents the dead cells. Each
experiment was carried out in triplicate (n=3) and five images were captured per well
to account for spatial distribution. Magnification: 20x, Scale bars: 50 μm.
6.3.3

Evaluation of mitochondrial activity

The metabolic activity of the epidermal and dermal cells after a 24 h exposure to the
different treatment groups is provided in Table 6.2. The values demonstrate a minimal

97

decrease in the mitochondrial activity of the HaCaT cells after exposure to AuNPs,
UOx, and HRP. The data further suggested a slight decrease in the activity to 0.87, at a
higher concentration of MWNCTs. The functionalized sensor showed decreased
activity (0.85) as compared to an unfunctionalized sensor (0.96), which is a result of
the active materials immobilized on the sensor. On the contrary, the dermal cells,
HDFa, showed higher sensitivity resulting in reduced mitochondrial activity in
comparison to HaCaT cells. The cell activity on exposure to AuNPs reduced to 0.83 at
a higher concentration, implying reduced cellular metabolic rate as Au interferes with
the oxidative pathway in the mitochondria. Previous studies have shown that smaller
NPs, result in the production of high superoxide levels resulting in mitochondrial
dysfunction.275 However, the cellular activity remained >0.85 for cells exposed to
MWCNTs, UOx, and HRP enzyme. Similar to the epidermal cells, the dermal cells on
exposure to an unfunctionalized sensor (0.91) showed higher activity levels compared
to a functionalized sensor (0.86). The results for all the treatment groups demonstrated
no effect on the metabolic activity of the dermal and epidermal cells at concentrations
present in the sensor.
Table 6.2. Resazurin mitochondrial assay. Mitochondrial activity in epidermal (HaCaT)
and dermal (HDFa) cells after a 24 h treatment with the different treatment groups,
quantified using the AlamarBlue assay. The presented data shows the results of three
independent experiments (n = 3). Values are presented as the mean ± SD.
Mitochondrial activity
Treatment

Concentration

Group

(µg/ml)

AuNPs

(Mean ± SD)
Epidermal cell line

Dermal cell line

(HaCaT)

(HDFa)

0.5

0.99 ± 0.01

0.88 ± 0.01

5

0.91 ± 0.02

0.83 ± 0.01
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MWCNTs

UOx

HRP

Sensor

6.3.4

50

0.99 ± 0.04

0.89 ± 0.05

0.001

0.92 ± 0.04

0.85 ± 0.01

0.01

0.89 ± 0.02

0.87 ± 0.01

0.1

0.87 ± 0.02

0.87 ± 0.01

0.2

0.91 ± 0.04

0.90 ± 0.03

2

0.92 ± 0.02

0.86 ± 0.01

20

0.93 ± 0.01

0.87 ± 0.01

0.02

0.98 ± 0.02

0.94 ± 0.05

0.2

0.96 ± 0.02

0.87 ± 0.01

2

0.99 ± 0.01

0.76 ± 0.01

Unfunctionalized

0.96 ± 0.02

0.91 ± 0.05

Functionalized

0.85 ± 0.03

0.86 ± 0.01

Evaluation of apoptotic activity

The apoptotic effect of the active materials and the sensor on the epidermal and dermal
cell lines after 24 h exposure was examined. All the treatment groups exhibited no
apoptotic activity, probably suggesting an alternative cell death pathway (necrotic or
induced due to ROS). For both the cell lines, exposure to AuNPs, MWCNTs, UOx and
HRP showed ~2.3% cells expressing apoptotic activity at the concentrations present in
the sensor (Table 6.3). A 2.67% and 3% of apoptotic cells were expressed on exposure
to a higher concentration of AuNPs for epidermal and dermal cell lines respectively.
Exposure to both the enzymes also resulted only in ~2% of apoptotic cells (Table 6.3).
Furthermore, the low percentage of apoptotic cells of ~2% demonstrated that the sensor
also showed no caspase-3/7 activity. The decreased apoptosis by the sensor may again
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be attributed to the reduced percolation of the nanomaterials through the enzyme
matrix. The obtained data indicate no apoptotic activity for any treatment group.

Table 6.3. Caspase 3/7 activity in epidermal (HaCaT) and dermal (HDFa) cells after a
24 h treatment with the different treatment groups, quantified using the Caspase-Glo
3/7 Assay. The presented data shows the results of three independent experiments (n =
3). Values are presented as the mean ± SD.
% Apoptotic cells
Treatment

Concentration

Group

(µg/ml)

AuNPs

MWCNTs

UOx

HRP

Sensor

(Mean ± SD)
Epidermal cell line

Dermal cell line

(HaCaT)

(HDFa)

0.5

1.33 ± 1.11

2.00 ± 0.67

5

2.33 ± 0.44

2.33 ± 0.88

50

2.67 ± 1.11

3.00 ± 0.67

0.001

1.00 ± 0.66

1.33 ± 0.88

0.01

1.67 ± 0.44

1.67 ± 0.88

0.1

2.33 ± 1.11

2.00 ± 0.67

0.2

1.33 ± 0.44

1.00 ± 0.67

2

2.33 ± 1.55

1.00 ± 0.67

20

2.33 ± 0.88

1.67 ± 0.88

0.02

1.00 ± 0.67

1.00 ± 0.67

0.2

1.67 ± 0.44

1.67 ± 0.44

2

2.00 ± 0.67

2.33 ± 0.88

Unfunctionalized

1.33 ± 0.44

1.00 ± 0.67

Functionalized

1.67 ± 0.44

2.00 ± 0.67
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6.4

Conclusion

This chapter investigated the cytotoxicity profiles of the active materials used in the
wound monitoring sensor and the sensor itself on human keratinocytes (HaCaT) and
fibroblasts (HDFa). The cell viability studies indicated that all the active materials in
the sensor and the sensor itself show no toxicity at IC70 dose at the concentrations
present in the sensor. Higher cell viability was observed when the cells were subjected
to functionalized sensors as compared to the individual active materials which was
attributed to the protective layer offered by the enzyme matrix. The resazurin assay
confirmed no impairment of the mitochondrial function induced by the active materials
and the sensor. The results established that the active materials and the respective sensor
incur a minimal loss in viability, mitochondrial damage, and showed no apoptotic cell
death on exposure at concentrations present in the sensor to both the epidermal and
dermal cell lines. The study confirmed that the fabricated sensor and its constituent
active materials are not toxic in in vitro studies. The results from this investigation pave
the way towards further testing on in vivo wound model systems.
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7
7.1

Clinical Validation of the Uric Acid Monitoring Sensor

Introduction

Venous leg ulcers represent one of the most prevalent forms of chronic wounds
especially in the US affecting 600,000 people annually.276 They require a significant
amount of healthcare resources with an estimated annual treatment cost of $2.5-3.5
billion.277 Moreover, around one-third of the treated patients experience a recurrence of
the ulcerations, resulting in a reduced quality of life.278 The molecular biology of these
wounds differs significantly from healing wounds, with various factors affecting the
healing rate.279–281 Treatment of these ulcers is costly and time consuming with patients
requiring multiple clinical visits.282 Standard clinical guidelines recommend color
duplex ultrasonography or Doppler measurement to assess the outcomes of the wound
treatments which requires expensive equipment and skilled personnel.283,284 There is a
need for technologies that can assess the healing efficacy of the provided treatments in
real-time to allow for efficient wound care management.
Physical and chemical assessment parameters of the wound environment such
as pH and pressure,144,145,147,173 bacterial metabolites,148,149, and purine metabolites150–
153

have provided alternatives to subjective measures like visual inspection, optical

techniques285 or, wound size measurements142,143 enabling continuous wound
monitoring. These sensing approaches offer significant advantages for longitudinal
measurements providing real-time information about wound health. Sensors integrated
directly onto wound dressings, also termed as “smart bandages”, allow for easy
integration of the sensors on the wound without causing any patient discomfort. As
mentioned in the earlier chapters, UA, a purine metabolite is known to have a direct
correlation with the different stages of wound healing. It has been shown that UA
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measurement can provide real-time assessment of the wound status enabling a way
towards effective and timely therapeutic interventions for improved patient care at a
personalized level.251 Several smart bandages have been reported for electrochemical
detection of UA in wound exudates on flexible sensor substrates. However, despite the
advancements in the development of these smart bandages for UA detection, no human
in vivo validation studies have been conducted with these sensors till date.
For the first time, this work aims to establish the feasibility of a wearable
electrochemical sensor for UA measurement in wound exudates through both, in vitro
and in vivo clinical validation studies. First, discarded wound dressings from venous
leg ulcer patients were collected to determine the efficacy of the electrochemical sensor
in vitro. The extracted biofluids from the dressings; wound exudate and sweat from the
healthy skin, were analyzed for UA presence to determine its feasibility as a wound
biomarker. An in vivo pilot study was then conducted, wherein the wearable sensor was
placed on venous leg ulcers to record real-time changes in UA levels for multiple days.
As an easy to apply and user compliant sensing system, the system may prove useful
for better clinical decision making, especially for patients suffering from chronic
wounds (e.g., venous leg ulcers). However, placing sensors in a complex environment
like a wound bed is associated with multiple issues such as biofouling, biocompatibility,
etc. especially for long-term measurements. We thus introduce a new approach for
measurement of UA levels in sweat produced in the perilesional area. The proposed
approach may provide a basis for near-wound sensing thus allowing for the
development of a fully non-invasive wound monitoring system.
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7.2

Experimental

7.2.1

Patients

Patients with an ulcer located in any extremity that attend the Wound Care Clinic at the
University of Miami Hospital, Miami, Florida were approached to participate.
Information from the patients that come for routine wound care and agree to participate
was collected and de-identified in a data collection spreadsheet. Study patients were
aged over 21 years of age and had a confirmed case of venous leg ulceration. For
patients suffering from multiple venous leg ulcers, only the larger ulcer was considered
as the target ulcer. A formal assessment was carried out by the doctors to determine the
eligibility of a patient, after which the potential patient was provided with a study
information sheet and asked to sign an informed consent form (ICF). After signing the
ICF the patient’s ulcer was treated with Standard of Care; i.e. standard compression
therapy for a venous leg ulcer debridement.
Patient inclusion criteria
Patients of any gender or race that attend the Wound Care Clinic with a chronic ulcer
who meet the below requirements could be asked to participate in the study:

1. Presence of a chronic venous leg ulcer as confirmed by the Clinical-EtiologicalAnatomical-Pathophysiological (CEAP) clinical assessment that
a. Has been present for over 4 weeks
b. Ulcer located in any extremity
c. Exudes a nominal amount of wound fluid for the sensor to function
accurately
2. Over 21 years of age
3. Willing to apply the sensor over the wounds as directed
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4. Able to provide an informed consent
5. Able to understand and comply with the requirements of the study

Patient exclusion criteria
1. Failure to satisfy ANY ONE of the inclusion criteria
2. History or active osteomyelitis
3. Has active cellulitis
4. Has gangrene
5. Has an ulcer located on the trunk
6. If the Ankle Brachial Index (ABI) is greater than 1.3, the investigator will use
clinical judgment to determine if vascular insufficiency exists
7. Any experimental drugs taken or applied topically to the wound for 4 weeks
preceding the study and for the duration of the study

Patient consent
Before the recruitment of any patient for the study, a detailed explanation of the nature
and purpose of the study was provided. Patients were given enough time to read the
consent carefully and were encouraged to ask questions. Once the essential information
was provided and it was established that the patient understands the implications of
participating in the study, the patients were asked to sign an informed consent. Once
the patient signed the consent, we proceeded with the dressing placement.

Criteria for withdrawal
Patients were advised that they may withdraw from the study and remove the placed
sensor at any time, for any reason or if necessary. On patient withdrawal, the reason
was fully documented in the notes.
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Screening evaluation
The study was designed to typically last for one week during which time the patients
were required to wear the sensors along with the compression bandages. Prospective
patients were fully informed about all the aspects and the intent of the study, including
its procedures, risks, and benefits. Receipt of acknowledging the information provided
was the signed informed consent provided by the patient.

7.2.2

Wound dressing collection and uric acid extraction

Discarded wound dressings from four de-identified subjects were collected from the
Wound Care Center at the University of Miami for UA analysis. Allevyn hydrocellular
foam dressings (10 cm x 10 cm) were placed on four de-identified subjects with varying
etiologies. Two dressings were placed on each subject; one on the wound bed and
another on the adjacent healthy skin for three days.
The dressings placed over the wound were used to extract two different
biofluids; wound exudate and extract from perilesional skin. Samples of 4 cm × 4 cm
area were cut from the dressings for UA extraction. As shown in Figure 7.1, the red
boxes represent the wound exudate area, while the blue boxes represent the extract from
the perilesional skin area. The perilesional skin areas were cut at a distance of 5 cm
from the center of wound exudate areas to maintain a sufficient distance from the
wound region. The dressings placed on the healthy skin were used to extract the biofluid
(4 cm x 4 cm); as represented by the green boxes in Figure 7.1. These dressing samples
were immersed in a NaOH buffer solution (0.1 M, pH 13.0), followed by a ramped
heating from 37oC to 60oC at a rate of 5oC min-1. The solution was then ultrasonicated
using a homogenizer for 60 s at 20 Hz and subsequently centrifuged at 2000G for 5 min
to separate the debris from the solution. The extracted biofluids were used for
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measuring UA concentrations using the electrochemical sensor and a standard
colorimetric assay purchased from ThermoFisher Sc.

Figure 7.1 Images of discarded wound dressings from four de-identified subjects 1 to 4
respectively. The boxes in the figures represent the 4 cm x 4 cm sample areas. Red
boxes represent the wound exudate region, and the blue boxes represent the extract
from perilesional skin areas, while the green boxes are extracts from healthy skin.
7.2.3

Wound dimension measurements

The ruler method was used to record the physical measurements of the wound. The
wound width and length were measured using a ruler, by recording the longest length
and widest width across the wound edges. The wound depth was measured by applying
a Q-tip at the deepest wound base region, while marking the level of the wound edge
and measuring it using a ruler.
7.2.4

Uric acid sensor placement on wounds

The flexible wound monitoring sensor was placed on the wounds of two de-identified
patients for three days. A multi-layer wrapping protocol was used for placing the sensor
on a wound. A cotton dressing (10 cm x 10 cm) was placed on the wound as the first
layer serving as a protective layer between the wound and the sensor surface. A cotton
dressing (10 cm x 10 cm) with the incorporated sensors was placed next with the sensor
107

surface facing towards the wound bed. The third compression layer consisted of an
Allevyn foam to absorb the excess wound exudate. A layer of high stretch fiber to
provide a gradient of pressure across the calf muscles was wrapped next. The final layer
was a short stretch fiber that was used to dynamically augment the pump action of the
calf muscles to ensure proper blood flow in venous leg ulcer patients.
7.2.5

Ethical considerations

This study has been carried out according to the protocol approved by the Florida
International University Institutional Review Board (IRB 20180305-IAA).
7.3
7.3.1

Results and discussion
In vitro sensor validation

Uric acid (UA), a product of the purine metabolic cycle, is considered to be an
endogenous biomarker for wound healing assessment. As a consequence of cell rupture
at the wound site, adenosine triphosphate (ATP) is released into the extracellular
matrix, where the final reaction in the pathway is the conversion of xanthine to UA.154
As a result of cell death there is local production of UA at the wound site, with the UA
levels decreasing as the wound heals, hence serving as a diagnostic indicator for wound
healing.155 To establish the feasibility of UA measurement in a wound and determine
the correlation between the wound physiology and the UA levels, four de-identified
patients diagnosed with active venous leg ulcer (C6) were analyzed. Wound exudate
and sweat collected from the patients were measured for the presence of UA. The UA
levels in the wound exudates were seen to be 2-4 times higher than in sweat from the
healthy skin (Table 7.1), confirming the localized production of UA in the wound
milieu. The sample from a patient with a wound size of 4.0 cm x 3.5 cm (Figure 7.2a)
was seen to have a UA concentration of 408.7 µM, while the subject with 2.5 cm x 2.1
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cm wound size (Figure 7.2b) exhibited a UA concentration of 127.9 µM. The wound
with a larger size was observed to have higher UA levels accumulated on the discarded
dressing, suggesting a correlation may exist between the wound size and the UA
concentration. However, further detailed validation is necessary with larger sample
studies to confirm the correlation. The UA levels determined using the electrochemical
sensor were further validated against a standard colorimetric UA assay. The average
recovery of the wound exudate samples was seen to be 86.49%, compared to a recovery
of 80% observed for the healthy sweat (Table 7.1); validating the high accuracy of the
sensor to measure UA in real samples.

Figure 7.2 Wound images of two de-identified subjects a. Subject 1 and b. Subject 2
diagnosed with a venous leg ulcer. The larger wound of the Subject 1 correlated to a
higher UA concentration, indicating a correlation between wound chronicity and UA
levels.
Table 7.1. Electrochemical detection of UA in wound extracts vs. standard colorimetric
UA assay. The high recovery values obtained confirmed the high efficacy of the sensor
to measure UA in real wound exudate samples. Each experiment was carried out in
triplicate (n = 3).
Subject

1

Sample

Wound exudate

UA

assay Biosensor

Recovery

RSD

(µM)

(µM)

(%)

(%)

413.80

408.69

98.77

3.7
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2

3

4

7.3.2

Perilesional skin 114.30

155.43

135.99

1.3

Healthy skin

101.30

95.65

94.42

5.7

Wound exudate

231.50

166.30

71.84

1.5

Perilesional skin 154.80

54.35

35.11

5.8

Healthy skin

96.30

44.19

45.89

4.7

Wound exudate

337.23

230.42

68.33

2.5

Perilesional skin 111.42

170.50

153.03

3.5

Healthy skin

89.36

67.81

75.89

1.5

Wound exudate

119.48

127.87

107.03

4.5

Perilesional skin 38.65

34.72

89.83

2.9

Healthy skin

23.00

65.68

2.5

35.02

In vivo sensor validation

After establishing the feasibility of UA measurement in wound extracts, the fabricated
sensors were validated through a pilot in vivo study. An array of four UA sensors
integrated onto a single dressing enabled us to map the UA levels across the wound
area, with each sensor programmed to collect data once per hour for one minute at 1.3
Hz. To map the UA levels across the wound area, two sensors were placed on the center
of the wound bed, while the other two were positioned on the wound edges (Figure 7.3a
and Figure 7.4a). The initially recorded low temperature (~25oC) values from the sensor
for both the subjects can be attributed to the time for while the sensor was run before
being placed on the patient. All the sensors placed on both the subjects exhibited a flat
line over the entire period of time (Figure 7.3b and Figure 7.4b).
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Figure 7.3 a. Photographs illustrating sensor placement steps on Subject 1. The wound
size of the patient was recorded to be 12.0 cm x 4.0 cm x 0.2 cm. b. Longitudinal current
response obtained from the four UA sensors placed on the subject for 72 h. An array of
four UA sensors integrated onto a single dressing was placed on the subjects to map
UA levels across the wound area. Sensors 1 and 4 were placed on the wound edges
while sensors 2 and 3 were placed in the center of the wound for both the subjects.

Figure 7.4 a. Photographs illustrating sensor placement steps on Subject 2. The wound
size of the patient was recorded to be 7.5 cm x 5.6 cm x 0.5 cm. b. Longitudinal current
response obtained from the four UA sensors placed on the subject for 24 h. An array of
four UA sensors integrated onto a single dressing was placed on the subjects to map
UA levels across the wound area. Sensors 1 and 4 were placed on the wound edges
while sensors 2 and 3 were placed in the center of the wound for both the subjects.
Wound microenvironment is highly dynamic and complex with several
unknown factors adding to the ambiguity of the sensor environment. The results
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obtained from the pilot study suggested several potential reasons that may affect the
sensor functionality when placed in vivo. As discussed in the earlier chapters, a change
in parameters like pH and temperature of the biofluid can result in a loss of enzymatic
activity. The in vitro stability studies confirmed this effect showing a decrease in the
sensor functionality after two days. Although a higher rate of activity degradation of
the enzyme maybe assumed when placed in vivo, an immediate loss is unexpected. A
wound microenvironment contains a myriad of proteins and chemicals, of which some
may exhibit a competitive inhibition towards the uricase enzyme,286,287 with a possible
effect of such inhibition being loss of sensor functionality. But, since the developed
sensor was able to successfully detect UA in the collected wound exudates, it may be
possibly concluded that these compounds are unlikely to cause significant interferences
in the sensor signal. A probable reason for the observed loss in sensor functionality was
thus hypothesized to be sensor biofouling. Whilst further clinical validation studies are
required in order to derive conclusive results, the biofouling phenomenon and its
consequent effect on the sensor functionality was explored further.

7.3.3

Sensor biofouling through biofilm growth on active area

Apart from the extracellular components present in a wound exudate, a wound milieu
tends to develop a biofilm within 24 hours288,289 due to manifestation of infections,
hampering the wound healing significantly. As discussed earlier, the sensing of
complex matrices such as a wound exudate is challenging due to sensor fouling
resulting from adsorption of wound debris. However, formation of these biofilms
(Figure 7.5) on the active surface area of the electrode can further compromise the
sensor response and its long-term stability. Most knowledge of biofilms developed in
chronic wounds has been derived from studies of Pseudomonas aeruginosa (P.
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aeruginosa) and Staphylococcus aureus.290,291 In vitro studies were carried out wherein
the P. aeruginosa bacterial strain (PA01) was grown over the sensor surface to study
the growth of biofilm with time. It was hypothesized that growth of such biofilms will
foul the sensor and result in a degraded UA response from the sensor.

Figure 7.5. Schematic illustration of biofilm formation on the wound bed and the sensor
surface. The biofilm layer formed on the sensor surface will act as a physical barrier
impeding the diffusion of UA from the wound exudate to the active area of the sensor
surface, thus resulting in sensor fouling over time.

The scanning electron micrographs recorded at different time points revealed a
complete surface coverage by the biofilm after 3 days (Figure 7.6). The growth of
biofilm over the sensor surface was further validated by the decrease in current response
as a function of time. The electrode with the growing biofilm was seen to exhibit a 20%
higher sensor fouling rate compared to the control electrode (no biofilm growth) after
a period of seven days (Figure 7.7). The biofilm acts as a passivating layer on the
electrode, impeding the diffusion of UA from the wound fluid to the electrode surface.
The resulting concentration gradient of UA (lower at the electrode surface) thus results
in a decreased sensor response. Additionally, the change in pH in the wound
environment due to biofilm formation, can also affect the catalytic activity of the
uricase enzyme further resulting in a sensor drift. This study ascertained that biofouling
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has a significant effect on the sensor response and must be taken into consideration
when the sensor is placed on the wound.

Figure 7.6. SEM images of biofilm growth on a MWCNT/Au/HRP/UOx functionalized
sensor surface at different time points (0 h, 24 h, 72 h and 120 h). The biofilm was seen
to completely cover the active area of the sensor surface after 72 h, hindering diffusion
of UA to the sensor surface.

Figure 7.7. Current response of a MWCNT/Au/HRP/UOx functionalized sensor as a
function of time when subjected to media with (biofilm) and without (control) a
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growing biofilm. The higher degradation rate of the sensor response observed for the
sensor with growing biofilm, showed the hindered diffusion of UA to the sensor. Each
experiment was carried out in triplicate (n = 3) and the data is represented as mean ±
SD.
7.3.4

Electrochemical monitoring of biofilm growth

In view of the fact that biofouling significantly impedes the sensor functionality, real
time monitoring of these biofilms is essential. Previous literature suggests that biofilms
produce lactic acid (LA)292 in the wound environment resulting in a relatively acidic
environment. Measurement of parameters like LA and pH may thus be utilized to assess
the temporal growth of these biofilms in chronic wounds. The same bacterial model
used in the biofouling study showed a proportional increase in the lactic acid levels as
a function of biofilm growth, implying a direct correlation between the biofilm growth
and LA production (Figure 7.8a). Additionally, the pH levels were also seen to decrease
from 7.0 to 6.0 confirming the acidic environment as a result of the increasing bacterial
count in the environment (Figure 7.8a and b).

Figure 7.8. a. Change in lactic acid levels and pH levels and b. bacterial count as a
function of biofilm growth at different time points (0 h, 24 h, 48 h, 72 h and 96 h).

This led to a sensor redesign wherein an enzymatic lactic sensor was developed and
added to the wound sensing suite to monitor the growth of these biofilms (Figure 7.9a
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and b). For the first time, this study reports a wound monitoring sensing platform that
can measure UA for monitoring the wound healing progression in conjunction with a
LA sensor for monitoring sensor biofouling.

Figure 7.9. a. Amperometric response of the developed lactic acid sensor to varying
levels of lactic acid. and b. Calibration curve showing a linear correlation between the
current and the lactic acid concentration.

This multimodal sensing platform monitoring the wound healing and biofilm
development can be leveraged in the future to develop a better understanding of the
wound microenvironment and its effect on the electrochemical sensor response. The
developed correlation between lactic acid production and biofilm growth could be
further utilized to monitor the development of infections in the wound milieu to provide
timely therapeutic assessment.
7.3.5

Feasibility of UA measurement in wound proximity

The positioning of the biosensor directly over the wound bed can lead to a lower sensor
accuracy owing to occlusion of the active surface by the wound debris. An approach
towards UA sensing in the wound proximity could open up a potential way for
continuous wound monitoring. When an injury occurs, the cells begin to die resulting
in the production of UA in the wound milieu. With the accumulation of UA at the
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wound site, some UA passively diffuses from the extracellular fluid to the blood serum.
The generated electrochemical gradient further facilitates the diffusion of serum UA to
the eccrine sweat glands present in the wound vicinity. UA concentration in three
different biological fluids; namely, wound exudate, sweat from perilesional skin, and
sweat from healthy skin was evaluated using the standard addition method. The
concentration trend in these biofluids for each patient is depicted in Figure 7.10.

Figure 7.10 Trend in UA concentrations found in the wound exudate (1), perilesional
skin extract (2), and healthy skin extract (3). The higher UA levels in the perilesional
skin extract can be used for a non-invasive near-wound sensing approach. Each
experiment was carried out in triplicate (n = 3) and the data is represented as mean ±
SD.
As observed from the real samples, the wound exudate showed the highest UA
concentration, followed by the biofluid extracts from perilesional skin and healthy skin
for all the subjects. The higher levels of UA observed in the biofluid from the
perilesional skin as compared to the healthy skin can be ascribed to the passive transport
of UA in the surrounding sweat glands. The presence of elevated UA levels in the
biofluid extract from perilesional skin can be used as a potential biomarker paving the
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way towards a new near-wound sensing approach. It can help prevent occlusion and
electrode fouling effects, and biocompatibility issues that result from embedding the
sensor directly over the wound bed. The measured UA levels were validated against a
standard colorimetric UA assay, and an average recovery of ~103% was observed for
the biofluid extracts from perilesional skin (Table 7.1).
7.4

Conclusion

A clinical validation has been conducted to determine the feasibility of UA detection
in chronic venous leg ulcers using a wearable wound monitoring system. Preliminary
in vitro studies involved the extraction of wound exudates from discarded wound
dressings. The collected dressings tested positive for UA presence, establishing the
feasibility of using UA as a biomarker for wound monitoring. The UA levels in wound
exudate were found to be 2-5 times higher than the levels found in sweat, confirming
the local production of UA in the wounded area. The developed sensor exhibited a
recovery of >85% showing the high accuracy of the electrochemical detection
mechanism used by the sensor. Subsequently, an integrated flexible wound monitoring
system was placed on venous leg ulcer patients for real-time UA monitoring. An
optimized wrapping protocol for the placement of the sensors on the wounds was
established. The studies indicated a loss of sensor functionality when placed on real
wounds, where biofouling was attributed to be a major factor. A new sensing platform
was developed for the first time that can monitor the wound progression and biofilm
development simultaneously. Further, a new near-wound sensing approach has been
presented, where the biofluid extracted from the perilesional skin was seen to have
elevated levels of UA compared to the healthy skin extract. Based on this, biofluid
extract from perilesional skin can be utilized for biosensing within the wound
proximity, preventing electrode fouling and biocompatibility issues, simultaneously
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improving the lifetime of the biosensor. The real sample results from the biosensor
correlated well with the conventional colorimetric UA assay, establishing the practical
usability of the sensor. The near-wound sensing methodology can enable a new
approach towards long-term wound monitoring. Future clinical studies focused on
healing wounds could help determine a more precise correlation between the UA levels,
the wound chronicity and the wound healing progress.
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8
8.1

Summary and Outlook for the Future of Wearable Sensing Systems

Summary

The present doctoral thesis studies how the dynamic sensor environment affects the
sensor response and develops correlations between them to acquire accurate actionable
data. In particular, the research investigates the dynamic parameters in the sensor
environment and correlates them with experimentally measured behavior exploiting
wound monitoring as a use case. The thesis first reviews the importance of wearable
chemical sensing, with particular emphasis on enzymatic electrochemical sensors.
Chapter 1 discusses the challenges of the current wearable chemical sensors and how
the dynamic variability offered by the biofluid affects the sensor response. The wound
bed is considered to be a classic example of a dynamic environment with several
parameters (e.g., pH, temperature, analyte flux, evaporation) changing as a function of
the wound healing status. The following chapter presents an enzymatic electrochemical
sensing approach towards continuous wound monitoring through sensing of a purine
metabolite, uric acid. The sensor utilizes a nanocomposite-based architecture coupled
with a bi-enzymatic system to facilitate faster reaction kinetics. The sensor response at
low overpotentials allowed for specific detection of UA with negligible effect from
interfering compounds. Furthermore, the high stability of the sensor exhibited at
physiological conditions demonstrated the applicability of the sensing architecture in a
wearable setting.
The thesis further discusses a novel fabrication approach for highly flexible
textile-based wearable electrochemical sensors. The chapter presents a facile and
inexpensive process for the integration of flexible electrochemical sensors on textiles
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to ensure user comfort and wearability. Such sensors can be easily integrated onto any
garment ensuring no skin irritation while vigilantly monitoring the chemical parameters
of the wearer. The mechanical characterization of the sensors revealed that a tensile
strain of up to 100% and flexural strain of up to 180o has a negligible effect on the
mechanical properties of the fabricated sensor. The sensors were also shown to have a
minimal impact (~3% deviation) on the electrochemical characteristics of the sensor
when under mechanical deformation. The fabricated sensors were heat transferred to
wound dressings for enzymatic electrochemical sensing of uric acid in a steady-state
environment using the reaction mechanism established earlier. The high sensitivity of
the flexible sensors enabled measurement of uric acid in the clinically relevant range.
Owing to the mediator-free enzymatic approach, the sensor achieved stable and
accurate measurements over a period of seven days under physiological conditions. The
flexible sensors were further integrated with a backend wearable system-on-chip to
allow for real-time data collection and transfer to realize an integrated wound
monitoring system. While the UA sensing through this system exhibited a lower
sensitivity owing to the poor noise filtration mechanism of the miniature potentiostat,
the sensor was capable of UA detection in the medically relevant range. The variations
in the wound fluid composition among individuals, leads to an uncertain environment
in which the sensor is placed. The dynamic variability offered by these biofluids in any
wearable construct can result in a confounded sensor response. The effect of potential
dynamic environmental parameters like pH, temperature, sample volume and
evaporation on the sensor response is discussed in the following chapter. The effect of
these parameters on the mass transport kinetics of UA has been elaborated upon and
calibration models have been developed. The sensor was observed to behave optimally
in a pH range of 7.5 – 8, with the sensor response being higher at lower temperatures
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owing to the higher enzymatic activity. Biofouling was identified as another major
factor affecting the sensor response especially in complex biomatrix like wound
exudate. The confounding of sensor response as a result of biofouling was explored
further. It was observed that as a result of biofilm formation on the active area of the
sensor surface, UA diffusion was inhibited, reflected as a decrease in the current
response as a function of time.
On establishing the feasibility of UA measurement on the flexible sensors, the
sensor materials and the sensor itself were investigated for their cytotoxicity. The
wound sensor incorporates biochemical sensors that are placed in direct contact with
the tissue and wound fluids. An open wound exposes the underlying human tissue,
potentially subjecting it directly to the materials integrated within the sensor. The effect
of the sensor and the constituent materials were investigated on human keratinocytes
and fibroblasts to elucidate the toxicity mechanisms of each material. The time-lapse
studies indicated that the materials in the sensor show minimal toxicity at the
concentrations present in the sensor both at a cellular and intracellular level
(mitochondrial and DNA damage). Likewise, the materials and the sensor exhibited no
considerable impairment of the mitochondrial function or apoptotic activity on
exposure at concentrations present in the sensor. The functionalized sensor was seen to
exhibit lower toxicity compared to material mixtures. This improved biocompatibility
of the sensor was attributed to the biocompatible protective layer offered by the enzyme
matrix resulting in reduced leaching of the nanomaterials.
The work then presents the first ever demonstration of an in vivo study carried
out on patients suffering from chronic wounds using a wearable wound sensor. A pilot
trial is conducted to determine the feasibility of UA detection in chronic venous leg
ulcers through both in vitro and in vivo clinical studies. The in vitro studies revealed
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the concentration of UA in wound exudates to be 2-5 times higher than the levels found
in sweat, establishing the feasibility of UA as a biomarker for wound monitoring.
Subsequently, the integrated flexible wound monitoring system was placed on venous
leg ulcer patients for real-time UA monitoring. The measurements led to the
redesigning of the sensor, where a sensor platform capable of simultaneously
monitoring wound health and sensor biofouling is reported for the first time. A nearwound sensing approach is further presented in the chapter, where the biofluid extracted
from the perilesional skin was seen to have elevated levels of UA compared to the
healthy skin extract. Based on this, biofluid extract from perilesional skin can be
utilized for biosensing within the wound proximity, preventing electrode fouling thus
improving the lifetime of the biosensor. The thesis overall presents the feasibility of
stable UA measurement using the presented wound monitoring system both in
laboratory (in vitro) and in vivo scenarios. The work elaborates on the transition of
electrochemical sensing platforms from rigid to flexible and from steady-state to a
dynamic-state environment. All the above parameters are taken into consideration to
develop a robust sensing system providing accurate real-time data.
8.2

Future Outlook

The wearable technology market has been evolving at a rapid rate. This technology has
proven potential to alter the future of medical industry and healthcare providers.
Continuous monitoring of a person’s vitals provides an opportunity for improved
healthcare management. Easy access to a personalized database of a patient’s medical
history can enable the doctors to provide efficient treatments especially for patients
with restricted medical facilities. Moreover, with the advent of artificial intelligence
and machine learning techniques the data collected from these wearable devices can
allow for predictive analytics for timely medical interventions. In the recent years, apart

123

from wearable physical sensors, significant progress has been made in the field of
wearable electrochemical sensors. However, several fundamental and technological
challenges still remain to fully realize their potential. A deeper understanding of the
underlying biological relationships between the analyte concentrations found in
biofluids like sweat and saliva to blood analyte concentrations are required to establish
accurate correlations. The dependency of these analyte levels on the physiological
processes should also be investigated for biologically relevant measurements.
Fabrication of these sensors on different substrates based on the wound type
should be explored in the future. Mimicking the wound fluid dynamics and
understanding the flow as a function of the substrate properties and its impact on the
sensor response may help improve the sensor functionality when placed in vivo.
Fundamental theoretical frameworks should be developed in order to elucidate the
effects of the dynamic parameters on the sensor response and study the interdependency
of these parameters. Technologies to measure these parametric values in an in vivo
setting and on-chip feedback correction for the sensor response can result in improved
sensing systems. In addition, core analytical sensing challenges such as sensitivity,
selectivity and reproducibility of the sensors require to be addressed. Levels of certain
analyte in biofluids like sweat are in the nanomolar range and novel sensing
mechanisms are essential to enable sensing at a molecular level. Quantum technology
has enabled the development of highly sensitive optical sensors and perhaps
translational of such concepts to electrochemical sensing could lead to a new generation
of wearable chemical sensing devices. Interdisciplinary solutions are required to
address the above issues and enable the development of next-generation wearable
technology. In particular, for wound monitoring sensors, the sensing systems need to
be incorporated in conjunction with therapeutic systems to provide an active feedback
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to control the drug release profile based on the wound status. This will enable the
development of self-sufficient bandages reducing the need for multiple hospital visits
especially for patients suffering from chronic wounds. Apart from the core sensing
challenges, strategies for seamless integration of the sensing systems to other
subsystems such as backend electronics for data collection is vital. As a result of the
body movement, mechanical stress on the interface is likely to happen rendering the
system susceptible to failure. Flawless integration of these subsystems is extremely
crucial to facilitate the development of such sensing systems. It is evident that wearable
electrochemical sensors hold considerable promise to revolutionize personalized
healthcare, however innovative interdisciplinary solutions are required to realize these
systems.
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APPENDIX 1
Sensor Toxicity Assessment using Image Analysis
Chapter 6 detailed the toxicity assessment of a wound monitoring sensor and its
constituent active materials through in vitro assays carried out on human keratinocytes
(HaCaT) and fibroblasts (HDFa). To assess the toxicity profile, all the treatment groups
were investigated at different concentrations and time points using the gold standard
MTT assay. The toxicity profile of the treatment groups was further assessed by
performing fluorescence staining using the Live/Dead Cell assay (Thermo Fisher). This
appendix provides the cell viability values calculated using analysis of the captured
images.
The Live/Dead cell assay works on a simple method of differential staining
where fluorescent dyes, ethidium homodimer and calcein AM, are used to stain the
dead and live cells respectively. Ethidium homodimer intercalates in the DNA of dead
cells due to loss of plasma membrane integrity, while calcein AM is an amine-reactive
cell membrane permeant dye that binds to a live cell. Differential staining was
performed using these dyes and images were captured using a fluorescence microscope
(objective: 20x) at different concentrations and time points. Each experiment was
carried out in triplicate (three independent wells) and five images were captured per
well to account for the spatial cell distribution. In summary, a total of 15 images were
captured for a treatment group at a given concentration and time point. This assay was
carried out as a supporting study to the quantitative MTT assay. The captured images
were analyzed using a manual cell counting method, based on which the percent cell
viability was determined using the below formula (ref),

% 𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =

𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠

𝑥 100
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Equation 1

For a treatment group at a given concentration and time point, the cell viability for each
of the 15 images was calculated first, following which the cell viability obtained from
the five images captured per well was averaged. For the final cell viability, we
computed the mean and standard deviation by averaging the cell viabilities obtained
from each independent well. These calculated cell viability values for the dermal and
epidermal cell lines are provided in Table 1 and 2 respectively.
Table 1. Cell viability of dermal cells (HDFa) on exposure to the different treatment
groups at 12 and 24 h time points. The cell viability values as calculated from image
analysis. Five images were captured for each well (n = 3) to account for the spatial cell
distribution. All the data is presented as mean ± SD obtained from the images.
Cell viability (%)
Treatment

Concentration

Group

(µg/ml)

(Mean ± SD)
12 h
AuNPs

MWCNTs

UOx

HRP

24 h

0.5

80.32 ± 3.52

95.29 ± 1.38

5

77.13 ± 2.49

92.13 ± 3.43

50

81.36 ± 4.79

84.32 ± 1.29

0.001

82.40 ± 0.50

92.97 ± 3.42

0.01

75.79 ± 1.26

89.37 ± 3.94

0.1

81.61 ± 5.31

80.63 ± 6.95

0.2

80.49 ± 5.19

83.87 ± 1.97

2

83.22 ± 6.41

87.37 ± 1.96

20

80.44 ± 0.82

84.02 ± 3.51

0.02

83.94 ± 3.38

92.78 ± 4.95
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Sensor

0.2

77.36 ± 7.44

82.24 ± 5.17

2

84.73 ± 2.99

85.53 ± 0.92

Unfunctionalized

84.06 ± 2.40

83.69 ± 1.56

Functionalized

82.76 ± 2.42

76.35 ± 3.91

Table 2. Cell viability of epidermal cells (HaCaT) on exposure to the different treatment
groups at 12 and 24 h time points. The cell viability values as calculated from image
analysis. Five images were captured for each well (n = 3) to account for the spatial cell
distribution. All the data is presented as mean ± SD obtained from the images.
Cell viability (%)
Treatment

Concentration

Group

(µg/ml)

(Mean ± SD)
12 h
AuNPs

MWCNTs

UOx

HRP

Sensor

24 h

0.5

87.73 ± 7.21

89.48 ± 2.49

5

84.59 ± 8.06

89.42 ± 7.87

50

84.86 ± 2.15

89.68 ± 1.90

0.001

88.38 ± 5.74

90.34 ± 0.38

0.01

83.99 ± 1.93

92.25 ± 2.38

0.1

88.07 ± 0.30

92.65 ± 2.73

0.2

88.64 ± 6.58

92.75 ± 5.84

2

88.19 ± 0.89

91.11 ± 6.70

20

85.50 ± 1.34

93.83 ± 0.84

0.02

87.01 ± 4.76

89.32 ± 3.30

0.2

86.97 ± 5.77

81.51 ± 0.32

2

79.75 ± 0.87

84.58 ± 7.65

Unfunctionalized

90.99 ± 2.41

92.48 ± 2.66

Functionalized

90.79 ± 4.58

86.25 ± 1.67
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The cell viability values calculated from the manual cell counting method followed a
similar trend to that of the values obtained from the MTT assay. For both the cell lines,
a time and dose-dependent decrease in cell viability was seen when treated with the
different treatment groups. The cell viability for each treatment group was observed to
be >70%, confirming no cytotoxic effect (IC70). The toxicity assessment carried out
using the cell counting method was in agreement with the results obtained with the
MTT assay for both the cell lines.
The raw images and the cell viability calculations for each image is available at
the following link,
https://fiuditmy.sharepoint.com/:f:/g/personal/pbhushan_fiu_edu/Eqm_AmXZzKpAuiPJ6vdp7tcB
0N8ZmgREabclmMCx7L000w?e=QF2i0q
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APPENDIX 2
Informed Consent Form
Title of Study: Continuous monitoring of Uric Acid levels in wound exudate
and its correlation with wound healing
Key Information: The following is a short summary of this study to help you
decide whether or not to be a part of this study. More detailed information
is listed later on in this form.
Why am I being invited to take part in a research study?
We ask you to take part in a research study because you have a wound in one of your
extremities for more than 4 weeks and we would like to place a biosensor embedded in
a gauze to monitor the characteristics of the secretions of your wound. A person who
takes part in a research study is called a research or study subject. In this consent form
“you” always refers to the research subject.
What should I know about this research study?
•

Someone will explain this research study to you.

•

Whether or not you take part is up to you.

•

You can choose not to take part.

•

You can agree to take part and later change your mind.

•

Your decision will not be held against you.

•

You can ask all the questions you want before you decide.

PURPOSE
The purpose of this research study is to place a sensor in your wound to have a
continuous measurement of chemical parameters of the secretion of your wound,
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through an enzymatic biosensor designed by the Department of Electrical and
Computer Engineering at Florida International University, Miami.
Why is this research being done?
We would like to test a wearable sensor of wound secretion parameters. Wearable
sensors have the capacity for real-time health and environmental monitoring.
Continuous wound monitoring techniques can track healing visually or through
individual measurements and allow remote patient-physician engagements to enhance
quality of care and time and validate treatment based on data acquired at a personal
scale.
How long will the research last and what will I need to do?
We expect that you will be in this research study for 1 month. You will need to come
to your regular weekly clinic appointments for wound care and dressing changes.
During the dressing changes we will replace the monitor for a new one and your wound
will be treated with Standard of Care (e.g. in case of venous leg ulcers debridement and
compression therapy will be administrated). We will collect personal information such
as past medical and surgical history, medication history, wound specific information
such as ulcer size, ulcer duration, current and prior treatment of ulcer. Photographs of
the ulcer and healthy skin nearby to the wound will be taken. A sensor will be placed
over the wound and over nearby non-wounded area on the same limb. You will be asked
to return to the clinic in approximately one week to ensure proper healing, get dressing
changes and change the sensor to a new one. More detailed information about the study
procedures can be found later in this document under
“What happens if I say yes, I want to be in this research?”
Is there any way being in this study could be bad for me?
There is little if no risk to have allergic reactions to dressings.
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Will being in this study help me in any way?
There are no benefits to you from taking part in this research. However, since you are
going to receive a standard of care, we expect some improvement in wound healing.
What happens if I do not want to be in this research?
Participation in research is completely voluntary. You can decide to participate or not
to participate. You can say no now or leave the study at any time later. This will not
affect your care or benefits at UM/Jackson Memorial Hospital. The researcher may
remove you from the study if he/she believes that staying in the study is no longer in
your best interest. If you stop being in the study, the study staff will stop collecting
new information about you but they may need to use the information they have already
collected.
Detailed Information:
The following is more detailed information about this study, in addition to the
information listed above.
Who can I talk to?
If you have questions, concerns, or complaints, or think the research has hurt you, talk
to the research team at Dermatology and Cutaneous Surgery Research Office at
(305)689-3376.
This research has been reviewed and approved by an Institutional Review Board
(“IRB”). The Human Subject Research Office (HSRO) provides administrative support
to the University of Miami’s IRBs.
Please call the HSRO at 305-243-3195 if:
•

Your questions, concerns, or complaints are not being answered by the research
team.

•

You cannot reach the research team.
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•

You want to talk to someone besides the research team.

•

You have questions about your rights as a research subject.

•

You want to get information or provide input about this research.

How many people will be studied?
We expect about 20 people will be in this research study.
What happens if I say yes, I want to be in this research?
After signing Informed Consent your ulcer will be treated with Standard of Care, for
example, in case of venous leg ulcers debridement and compression therapy will be
administrated). Debridement (if necessary) will be performed after anesthetizing the
wound. Data collection will include personal information such as age, gender, race,
ethnicity, Body Mass Index, past medical and surgical history including medication
history. Wound specific information such as ulcer size, ulcer duration, current and prior
treatment of ulcer. Photographs of the ulcer and healthy skin nearby to the wound will
be taken. A small sensor will be placed over the wound and a nearby non-wounded area
on the same limb, and then appropriate dressings and compression therapy will be
provided. You will be asked to return to the clinic in approximately one week to ensure
proper healing, get dressing changes, and change the sensor to a new one.
What happens if I say yes, but I change my mind later?
You can leave the research at any time, it will not be held against you.
What if I get hurt as a result of my participation in this study?
Although risks are unlikely, if injury should occur, treatment will in most cases be
available. If you have insurance, your insurance company may or may not pay for these
costs. If you do not have insurance, or if your insurance company refuses to pay, you
will be expected to pay. Funds to compensate for pain, expenses, lost wages, and other
damages caused by injury are not available.
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What happens to the information collected for the research?
Efforts will be made to limit the use and disclosure of your personal information,
including research study and medical records, to people who need to review this
information. We cannot promise complete confidentiality.
We are asking you to let us collect some information from your medical records for this
study. We will not need to look at all your records. Instead, we will use a computer to
find information about your use of health care services, including:
•

clinic visits;

•

lab test results;

•

trips to the hospital;

•

medicines;

•

wound measurements;

•

pictures of your wounds.

If you are or have been, a patient at a University of Miami facility, you will have a
University of Miami medical record. We use an electronic medical record system
known as UChart, which improves access to information important to your medical
care. UChart will show that you are in a research study and a copy of this signed consent
form will be included. To provide as complete a record as possible, some or all of your
study-related research information may also be placed in UChart. This specifically
includes investigational drugs, devices, biologics, or anything else that may, separately
or together with other substances or activities, interfere with your clinical treatment or
place you at greater risk of harm. Other information from the research study may be
included as well.
This information will be available to University of Miami doctors, nurses, and other
authorized staff who may not be part of the research team but who are involved in
providing you medical care, or who are otherwise allowed to access your information.
The confidentiality of the results and other documents in UChart will be governed by
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laws, such as HIPAA, that concern medical records. We suggest that you tell any nonUniversity of Miami doctors that you are in a research study and that more information
may be made available to them at your request. The research team may use your
information to notify you of appointments, send you appointment reminders, or
schedule additional appointments.

Federal law provides additional protection of your medical records and related health
information. These are described in the University of Miami HIPAA authorization for
research known as Form B.
Will the information collected be used in future research?
Records will be in a locked cabinet in the Dermatology research office, 1321 NW 14
St, Room 504. Dressings will be sent to Dr. Shekhar Bhansali’s laboratory, Alcatel
Lucent Professor and Chair located at Florida International University, Department of
Electrical and Computer Engineering. The samples will be coded with a number but
with no patient identifying information. Once analyses of the samples are completed,
the samples will be destroyed.
Your information or samples that are collected as part of this research will not be used or distributed
for future research studies, even if all of your identifiers are removed.

What else do I need to know?
Your information and samples (both identifiable and de-identified) may be used to create products or
to deliver services, including some that may be sold and/or make money for others. If this happens,
there are no plans to tell you, or to pay you, or to give any compensation to you or your family.

PARTICIPANT’S STATEMENT/SIGNATURE
•

I have read this form and the research study has been explained to me.
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•

I have been given the chance to ask questions, and my questions have been
answered. If I have more questions, I have been told who to call.

•

I agree to be in the research study described above.

I will receive a copy of this consent form after I sign it.

________________
__________________
Signature of Participant

Date
________________

Printed Name of Participant

________________________________________________
__________________
Printed Name of Person Explaining Consent
(Investigator/Delegate)

________________________________________________
Signature of Person Explaining Consent
(Investigator/Delegate)
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